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Evaluation of Pulmonary Hypertension Using the Right to Left
Ventricular Diameter Ratio on Contrast-Enhanced Computed
Tomography
TETSUO ICHINOSE,1 YUJI NAKAZATO,1 HIROYUKI DAIDA,2 YOUICHI KATOH,1 TETSUYA OIGAWA,1
HAKUOH KONISHI,2 KOSEI TANIMOTO,1 YASUNOBU KAWANO,1 MIKI YAMASE,1 SHUTA TSUBOI,1
YUKI YOKOMATSU,1 HIROSHIGE YUU1
From The Department of Cardiology, 1Juntendo University Urayasu Hospital, Chiba; 2Juntendo University Hospital,
Tokyo, Japan
ICHINOSE ET AL.: Evaluation of Pulmonary Hypertension Using the Right to Left Ventricular Diameter Ratio
on Contrast-Enhanced Computed Tomography. Objective: To assess the severity of a right heart overload due to
pulmonary hypertension (PH), the estimated right ventricular systolic pressure (RVSP) determined by
echocardiography has generally been measured. The purpose of the present study was to evaluate the correlation
between the right to left ventricular diameter (RV/LV) ratio determined with contrast-enhanced computed tomography
(CE-CT) and the RVSP by echocardiography. Methods and Materials: 63 patients were enrolled and placed in two
groups consisting of those with or without a right heart overload that was defined as an RV pressure of more than
40 mmHg on echocardiography. PH was observed in 31 patients (PH group) and the remaining 32 patients exhibited
no PH (control group). In both groups, the RV and LV diameters were measured as the maximum inner diameter of
each heart chamber in the axial image obtained from the CE-CT. Results: The RVSP of the PH and control groups
was 58.5±20.7 mmHg and 26.1±0.4 mmHg, respectively. The RV/LV ratio for the PH group was significantly greater
than that of the control group (1.1±0.4 and 0.8±0.1, p<0.05). In both groups, the RV/LV ratio was correlated
(r2=0.21, p<0.05) with the RVSP. An optimal cut off value of the diagnostic value of the RV/LV ratio of above 1.0 in
the PH group had a sensitivity of 64.5%, specificity of 100%, positive predictive value of 100% and negative predictive
value of 74.4%. Conclusion: The RV/LV ratio significantly correlated with the RVSP and that ratio was a useful
parameter for diagnosing a right heart overload. (J HK Coll Cardiol 2010;18:44-52)
Computed tomography, Echocardiography, Estimated right ventricular systolic pressure, Pulmonary hypertension,
Right and left ventricular diameter
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1.1±0.4 vs 0.8±0.1
RV/LV>1.0
RV/LV
RVSP

RV/LV

p<0.05
64.5%

Introduction
Echocardiography has been recognized as a rapid
and non-invasive method for evaluating the right heart
overload. Using Doppler echocardiography, the right
ventricular systolic pressure (RVSP) has been shown to
be highly correlated with the pulmonary artery pressure
during right heart catheterization.1,2 The assessment of
pulmonary hypertension which suggests a right heart
overload has been performed by measuring the
estimated RVSP using echocardiography. However,
some studies 3-6 have reported that the right to left
ventricular diameter (RV/LV) ratio determined with
contrast-enhanced computed tomography (CE-CT) is
useful for assessing the severity of pulmonary thromboembolisms (PTEs). The purpose of the present
study was to evaluate the correlation between the
RV/LV ratio determined by CE-CT and the RVSP by
echocardiography.

Materials and Methods
1) Patient Characteristics
In this retrospective study, from December
2008 to March 2009, consecutive 63 patients were
divided into two groups consisting of those with or
w i t h o u t a r i g h t h e a r t ove r l o a d . I n s t a n d a r d
echocardiographical definition of pulmonary
hypertension (PH), maximum flow velocity and
pressure gradient of a tricuspid regurgitation
considered as more than 2.8 m/second and 30 mmHg
at a rest.7 If a right atrial pressure estimate of more
than 10 mmHg is used for PH, estimated RVSP of
more than 40 mmHg is reasonable to consider PH.
So the pulmonary hypertension group consisted of
those diagnosed with an estimated RVSP of more than
40 mmHg on the echocardiography, and the control
45

RVSP
100%

r2=0.21, p<0.05
100%
74.4%

group as those diagnosed with an estimated RVSP
of less than 39 mmHg. Those with an acute or active
stage of PH were excluded from this study. Other
exclusion criteria included (i) dilatation of
the thickness or lumen such as with a myocardial
infarction, pacemaker implantations, left bundle
b r a n c h b l o c k , l e f t ve n t r i c u l a r h y p e r t r o p h y,
or dilated and hypertrophic cardiomyopathy, and
(ii) pericardial involvement such as a pleural effusion
or pericarditis.
The baseline patient characteristics and
comorbidities are presented in Table 1. Sixty-three
patients (29 males and 35 females) were included in
this study. Thirty-one patients (mean age, 60.5±20.8,
13 males sand 18 females) were enrolled in the PH group
and the remaining 32 (mean age, 59.8±13.6, 16 males
and 17 females) in the control group. The clinical
pathogenesis of the PH was as follows; 9 patients with
congestive heart failure (6 with valvular disease, 1 with
hypertensive heart disease, 1 with atrial septal defect
and 1 with ischemic heart disease), 6 with malignant
disease, 5 with chronic obstructive pulmonary disease,
4 with pulmonary PTEs, 3 with primary pulmonary
hypertension and 4 with collagen disease. Maximum
pressure gradient of a tricuspid regurgitation in the PH
group and the control group were 3.5±0.6 mmHg and
2.2±0.3 mmHg (p<0.001), respectively. And its severity
were as follows, 49 with mild tricuspid regurgitation
(PH group, n=17, control group, n=32), 5 with moderate
tricuspid regurgitation (PH group, n=5) and 4 with
severe tricuspid regurgitation (PH group, n=4). The
patients received warfarin potassium (PH group, n=11;
control group, n=3), Beraprost sodium (PH group, n=5),
Bosentan hydrate (PH group, n=2), Sildenafil citrate
(PH group, n=3), diuretics (PH group, n=9; control
group, n=2) and depressors (calcium channel
antagonists, n=8, angiotensin converting enzyme
inhibitors (ACE-Is) and angiotensin II receptor blockers
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Table 1. Clinical basis of the disease in the 63 patients

Age (years)
Male/Female
BMI (kg/m2)
Comorbidities
Diabetes mellitus
Hypertension
Hyperlipidemia
Hyperuricemia

PH group
(n=31)

Control group
(n=32)

P value

60.5±20.8
13/18
21±5.4

59.8±13.6
16/17
23±3.7

7
14
7
5

2
15
5
1

NS
NS
NS
NS
NS
NS
NS
NS

CHF
Malignancy
COPD
PTEs
IPAH
Collagen disease

9
6
5
4
3
4

Malignancy
Vascular disease
Collagen disease
IHD
COPD
PTE
Infectious disease

15
5
6
2
2
1
1

All continuous variables are presented as mean±S.D.
BMI, body mass index; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease;
IPAH, idiopathic pulmonary arterial hypertension; PH, pulmonary hypertension; PTE, pulmonary thrombo-embolism.

(ARBs), n=14) and home oxygen therapy (PH group,
n=9). Four patients died from cancer (3) or a PH crisis
(1) after 7 months.

2) CE-CT Acquisition and Image Analysis
CE-CT was performed using a multi-detector row
helical CT scanner (Aquilion TSX-101A, Toshiba
Medical Systems Co. Ltd., Japan). The scanning
parameters were 120 kV, and 150~300A with 0.5 mm
thick sections. A nonionic iodinated contrast medium
(Iopamidol 612 mg/ml) was intravenously administered
at a total dose of 2 ml/kg and injection rate of 1.5 ml/
second, and the CT data were available after 70 seconds
from the start of the contrast medium injection. The
scanned images were retrospectively reviewed with a
DICOM viewer (ExaVision LITE, Ziosoft Inc., Japan).
The RV/LV ratio was evaluated by measuring the right
and left ventricular diameters of the heart in the axial
view of the transverse plane at the maximum point
between the inner surfaces of the lumen (Figure 1A).
The pulmonary artery trunk diameter (PA) and ascending
aorta diameter (Ao) were measured at the maximum
inner diameter of the transverse plane (Figure 1B).
J HK Coll Cardiol, Vol 18

3) Echocardiographic Data
Standard two-dimensional and Doppler
echocardiography were performed with a SONOS 5500
(Phillips Medial Systems Inc., USA) standard
ultrasound system with a 1 to 3 MHz wideband
transducer. The left ventricular diastolic dimension and
systolic dimension, left atrium dimension, ascending
aorta dimension, pulmonary artery dimension and
inferior vena cava dimension (IVC) were obtained in a
left parasternal, apical, and subxiphoid approach. The
estimated RVSP was calculated using the following
formula:
Estimated RVSP=4 × v2 # + Estimated RAP
#
, Bernoulli's formula; v, maximum flow velocity of
the tricuspid regurgitation; RAP, right atrium pressure.
The RAP was calculated as in Table 2.
A echocardiographic examination was performed
within 4 weeks of the CE-CT examination. Twoexperienced sonographers without any knowledge
of the CE-CT examination reviewed the patients
undergoing the echocardiography.

October 2010
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Figure 1. Axial image of the contrast-enhanced computed tomography. (A) Measurement of the RV/LV ratio. LV, left ventricle
inner maximum lumen diameter; RV, right ventricle inner maximum lumen diameter. The scan shows the measurements of the
maximum inner lumen diameter of the left and right ventricles. (B) Measurement of the PA/Ao ratio. PA, pulmonary artery inner
lumen diameter; Ao, ascending aorta inner lumen diameter. This scan shows the measurement of the ascending aortic inner
diameter and maximum pulmonary artery trunk inner diameter.

Table 2. Estimation of the right atrial pressure
IVC diameter
(mm)
12~15
12~15
15<
15<

Respiratory
variation*
+
+
-

Estimated RAP
(mmHg)
0~5
5~10
10~20
15~25

IVC, inferior vena cava; RAP, right atrial pressure.
*respiratory variations were positive when there was a greater than 50% variation of the minimum to maximum diameters of the IVC and
negative when there was less than a 50% variation in those diameters.

Results

4) Statistical Analysis
The results are expressed as the mean ± the
standard deviation (S.D.). The qualitative parameters
were compared by means of a t-test or Fisher's exact
test. A p value <0.05 was considered to indicate
statistically significant differences. A statistical analysis
was performed with a statistical software system (Stat
Mate III, ATMS Tokyo, Japan)

47

1) RV/LV Ratio
The estimated RVSP in the PH and control
groups were 58.5±20.7 mmHg and 26.1±0.4 mmHg,
respectively. The mean RV/LV ratio in the PH group
was 1.1±0.3, and differed statistically significantly
(p<0.05) from that in the control group (0.8±0.3)

October 2010

J HK Coll Cardiol, Vol 18

ICHINOSE ET AL.

(Figure 2A).
In both groups, the RV/LV ratio correlated
(r=0.46, r 2 =0.21, p<0.05) with the estimated
RVSP (Figure 2B). In a calculation from the
r e c e i v e r o p e r a t i n g c h a r a c t e r i s t i c s ( RO C )

curve, an optimal RV/LV ratio of more than 1.0
diagnosed PH with a sensitivity of 65%, specificity
of 100%, positive predictive value (PPV) of 100%
and negative predictive value (NPV) of 74%
(Figure 2C).

(A)

(B)

(C)

(D)

RV/LV ratio, right ventricular to left ventricular ratio; RVP, right ventricular pressure; PH, pulmonary hypertension.
Figure 2. (A) The RV/LV ratios between the PH and control groups. The estimated RVP in the PH and control groups from the
echocardiogram were 58.5±20.7 mmHg and 26.1±0.4 mmHg, respectively. The mean RV/LV ratio was significantly higher in the
PH group than in the control group (p<0.0001, t-test). (B) Scattergram illustrating the correlation between the right ventricular
to RV/LV ratio and estimated RVP in the PH and control groups. There was a significant correlation between the RV/LV ratio
and estimated RVP. The regression equation was determined as follows: RV/LV ratio=0.0077× estimated RVP+0.66 (r=0.46,
r2=0.21, p<0.0001 Fisher's test). (C) Receiver operating characteristic curve for the RV/LV ratio which diagnosed PH
≥40 mmHg). (D) Relationship between the RV/LV ratio and severity of the RVP. Moderate and severe RVP had a statistically
(RVP≥
higher RV/LV ratio than that of mild RVP.
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2) Other Parameters

1) RV/LV Ratio

The mean value of the PA/Ao ratios other than
for thoracic aortic aneurysms was 1.04±0.36 in the PH
group and 0.86±0.24 in the control group. The PA/Ao
ratio in the PH group was significantly higher (p<0.05)
than that in the control group (Table 3) and that ratio
statistically correlated with the RVSP (r 2 =0.23,
p<0.001). An optimal PA/Ao ratio threshold of more
than 0.9 calculated from the ROC curve diagnosed PH
with a sensitivity of 74%, specificity of 62%, PPV of
68%, and NPV of 69% (Figures 3A & 3B).
The RV and PA diameters were significantly
increased in the PH group (p<0.01 and p<0.001,
respectively). The LV and Ao diameters did not
statistically differ in the two groups (Table 3).

For PTEs, some literature3-6 has been available
for assessing the severity of the PH using CE-CT. Those
studies estimated that an RV/LV ratio of >1.5 indicated
the severity and the potential of dying from the PTE
within 30 days. Collomb et al.3 reported the severity
assessment of acute PTEs using CT. In their study, the
clinically severe PTE group had a statistically larger
RV/LV ratio than the non-severe PTE group (1.63 vs.
1.09, p<0.0001). Further, the diagnostic accuracy of an
RV/LV ratio of greater than 1.5 as a sign of a severe
PTEs occurrence had a sensitivity of 60%, specificity
of 83%, PPV of 83% and NPV of 76%. In our study,
clinically severe PH was defined as a patient death due
to PH, state of shock (systolic blood pressure of greater
than 80 mmHg) or New York Heart Association (NYHA)
class III-IV. In the ROC curve, if using an optimal
RV/LV ratio of more than 1.1, severe PH could be
accurately diagnosed with a sensitivity, specificity, PPV
and NPV of 79%, 88%, 65% and 94%, respectively,
which was comparable to the prior study. However, the
optimal cut off value of the RV/LV ratio differed
between our study and that of the previous study done
by Collombo et al. The reason was considered as
follows; in the acute phase of a severe PTE, the RV
chamber is enlarged and the LV collapses. However,
our study included all causes or stages of PH such as
right sided heart failure, and a chronic state of PH.
Therefore, the LV chamber size became compensated
to some degree and it was not necessary complicated

Discussion
Echocardiography is a non-invasive and rapid
imaging technique for demonstrating the signs of PH,
such as RV dilatation, leftward bowing of the
intraventricular septum (IVS), collapse of the LV and
the estimated RVSP. However, this examination has an
operator-dependent bias and the need for special
echocardiographic techniques. On the other hand, CT
is an objective examination. The purpose of this study
was to determine whether the RV/LV ratio of the CT
parameters could predict PH when compared with the
RVSP of the echocardiographic parameters.

Table 3. Results of the contrast-enhanced computed tomography parameters in the pulmonary hypertension and
control groups
Parameters
Maximum diameter
RV (mm)
LV (mm)
PA (mm)
Ao (mm)
RV/LV ratio
PA/Ao ratio

PH group

Control group

P value*

38.7±9.6
38.2±12.0
31.6±5.9
32.7±9.3
1.16±0.44
1.04±0.36

32.3±6.5
40.2±5.1
26.5±5.6
32.6±9.0
0.80±0.12
0.86±0.24

<0.05
NS
<0.05
NS
<0.05
<0.05

All continuous variables are presented as mean±S.D.
PA, pulmonary artery diameter; PA/Ao ratio, pulmonary artery diameter to aortic diameter ratio; PH, pulmonary hypertension; LV/RV ratio,
left ventricle to right ventricle diameter ratio. RV, right ventricular.
*The LV/RV ratio, PA/Ao ratio, PA, and RV significantly differed between the two groups (p<0.05).

49
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(A)

(B)
RV/LV ratio
PA/Ao ratio
RV diameter
PA diameter

AUC
0.77
0.66
0.68
0.74

Cut off value*
1.0
0.9
38.5 mm
28.5 mm

sensitivity
0.65
0.74
0.45
0.74

specificity
1.00
0.61
0.84
0.65

PPV
1.00
0.68
0.73
0.68

NPV
0.74
0.68
0.61
0.71

AUC, area under the curve; NPV negative predictive value; PH, pulmonary hypertension; PPV, positive predictive value;
RVP, right ventricular pressure.
≥ 40 mmHg). (B) The
Figure 3. (A) Receiver operating characteristic curve for all the parameters for diagnosing PH (RVP≥
≥40 mmHg).
accuracy of the parameters for predicting an echocardiographic diagnosis of PH (RVP≥
*the optimal cutoff levels were made available with a Youden index.
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by an LV collapse. In addition, the RV dimension was
enlarged with an increasing RVSP, however, the LV
dimension was not. That might demonstrate that the
optimal cut off value in our study was low compared
with the previous data. Nevertheless, the RV/LV ratio
was correlated with the estimated RVSP. If the patients
were divided into three groups based on the severity of
the RVSP with mild PH (30-39 mmHg), moderate PH
(40-69 mmHg) and severe PH (above 70 mmHg), the
RV/LV ratio for severe PH was significantly higher than
that for the moderate (p<0.05) and mild PH (p<0.001).
To the best of our knowledge there have been no
previous studies which have demonstrated a correlation
between the RV/LV ratio of the CE-CT and the severity
of the RVSP.
In two studies on massive PTEs, Contractor et
al. 8 and Lim et al. 9 reported that CT signs of RV
dysfunction (such as an RV/LV ratio>1.0, and leftward
bowing of the IVS) had a sensitivity of 78-92%,
specificity of 100% and PPV of 100%, as compared to
the echocardiographic findings of RV dysfunction (RV
dilatation, leftward bowing or paradoxical motion of
the IVS). In our study, using similar criteria, CT
demonstrated a sensitivity, specificity, PPV and NPV
of 50%, 100%, 100% and 79%, respectively for the
diagnosis of RV dysfunction. Only the sensitivity was
lower than that of those two studies despite the similar
specificity and PPV.
The CT images obtained in the axial view were
not similar to those in the four-chamber view. Quiroz
et al.10 reported that the CT measurements obtained from
the four chamber view images differed from those in
the axial view images. In acute PTEs, the RV/LV
ratio determined by the four-chamber view is more
correlative than that of the axial view with the clinical
adverse events including the mortality, necessity for
cardiopulmonary resuscitation, hypotension and rescue
thrombolysis. In our study, the RV/LV ratio was
analyzed by the axial view because of the advantage of
rapidly obtainable results without any reconstructionimaging process. However, if we had performed a
reconstruction from the four-chamber view, more
accurate data might have been obtained.
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2) Other Parameters
The RV diameter and RV/LV ratio determined
by CT have demonstrated a significant positive
correlation with the severity of PTEs or fatal outcomes,
whereas the LV diameter has shown a negative
correlation.3-6 In our study, the RV, RV/LV, PA, and
PA/Ao ratios exhibited a positive correlation to the
RVSP (the individual r indexes were 0.44, 0.46, 0.45
and 0.48 and r 2 indexes 0.19, 0.21, 0.20 and 0.23,
respectively. All p values were <0.001). On the other
hand, there was no correlation between the LV and
RVSP. The ROC curve for the RV/LV ratio, PA/Ao ratio,
RV and PA are demonstrated in Figure 3A and the
optimal cut off value is demonstrated Figure 3B.
In Ng11 and colleagues reported the correlation
between the PA/Ao ratio determined by CT and the
right atrial pressure (RAP) measured by right
heart catheterization in chronic PH patients with
cardiovascular and pulmonary disease. The PA diameter
and PA/Ao ratio were also correlated with the systolic
pulmonary artery pressure (PAP) (the individual
r indexes were 0.75 and 0.72, respectively, p<0.0005).
In the patients with the mean PAP measured by
catheterization, the accuracy values (sensitivity,
specificity, PPV and NPV) of a PA/Ao ratio of >1.0 in
predicting a diagnosis of PH, were 68%, 100%, 100%
and 52%, respectively. Those values for a PA diameter
of >30 mm were 70%, 92%, 96% and 52%, respectively.
Our data of the optimal cut off value for the PA/Ao ratio
and PA diameter are shown in Figure 3A. Although
the definition of PH and cut off value for the indices
differed, the PA/Ao ratio and PA diameter from our
study were less accurate in diagnosing PH than that
in Ng's study. The RV/LV ratio had the highest
accuracy among the four parameters constructing the
area under the curve (AUC) (Figures 3A & 3B). To
the best of our knowledge, no previous studies have
demonstrated the relationship between the RV/LV
ratio and estimated RVSP in PH due to various
diseases. Our study was the first to demonstrate that
the RV/LV ratio had a good correlation to the RVSP,
and that an RV/LV ratio of >1.0 was the most
powerful index for diagnosing PH.
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Study Limitations
The patient background in this study consisted
of the chronic stage of PH, because the CE-CT
examination was hard to perform during the active stage
of PH, particularly with congestive heart failure. This
evaluation may be useful for only patients in the chronic
stage of PH. Second, the end-diastolic ventricular
diameter may be obtained if an electrocardiogramsynchronized gating system is used together with CECT. However that technique increases the radiation
exposure and requires a specific gating system. Third,
in our study, right heart catheterization was not
performed, however the RVSP has been recognized to
have a good correlation to the PAP in previous studies1,2
More accurate results might have been obtained if the
PAP was measured by a right heart catheterization.
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In the Wireless Era: Leadless Pacing
KATHY LF LEE AND CHU-PAK LAU
From Department of Medicine, Queen Mary Hospital, Hong Kong
LEE AND LAU: In the Wireless Era: Leadless Pacing. Cardiac pacemakers have been the standard therapy for
patients with bradyarrhythmias for several decades. The pacing lead is an integral part of the system that serves as
a conduit for delivery of energy pulses to stimulate the myocardium. However, it is also an Achilles tendon that
directly causes most device complications both acutely during implant and chronically years afterwards. Both durability
and optimization of stimulation site are important areas of improvement for manufacturers and implanters. Elimination
of the pacing lead and utilization of other means for energy transfer is the only way to avoid lead complications and
allow better choice of stimulation site. Leadless pacing with ultrasound-mediated energy has been demonstrated in
animals and humans in acute studies. This has aroused intense interest in the field of cardiac pacing. With concerted
effort from the profession and the industry, leadless pacing may indeed become a sound idea. (J HK Coll Cardiol
2010;18:53-58)
Cardiac resynchronization therapy, Heart failure, Pacemaker, Ultrasound

Introduction
All pacing leads are associated with
complications like infection, fracture, failure and
dislodgment. Lead extraction is a high risk procedure.
With new device systems that often require implantation
of multiple leads, and with patients living longer, the
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incidence of lead complications becomes compounded
over time. 1 Therefore, there is a strong demand to
develop a pacing system that eliminates the pacing lead
as a conduit for energy transfer. Randomized clinical
trials on cardiac resynchronization therapy have
demonstrated its clinical benefits. Access to the left
ventricle is achieved with the use of a pacing lead to be
advanced into the coronary sinus and positioned in a
coronary vein branch. Implantation of this lead is
technically demanding and associated with a significant
incidence of failure to implant, implantation in a
suboptimal location, and complications.2,3 Comparing
to epicardial pacing, endocardial left ventricular
stimulation that minimizes the conduction delay from
the epicardium to the endocardium may be more
physiological and therefore give rise to greater
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hemodynamic benefits.4,5 Leadless pacing will enable
endocardial left ventricular stimulation without the risks
of systemic thromboembolism and mitral regurgitation.
It will also avoid diaphragmatic stimulation, avoid right
ventricular apical pacing, enable multi-site pacing, and
allow almost free choice of stimulation location within
the left or right ventricle. It may also address challenges
in pediatric pacing, and development of a truly MRIcompatible pacing system.

Acoustic Energy for Leadless Pacing
Many concepts have been patented for the
development of a leadless pacing system. Having a long
history and wide application in medical technology,
ultrasound energy is considered safe and was chosen
to prove the concept of energy transfer. The use of
ultrasound-mediated energy to drive a remotely
positioned electrode for direct myocardial stimulation
is the first to be reported in the medical literature. This
new technology uses the mechanical-to-electrical
properties of piezoelectric materials for transformation
of energy. The experimental set-up include: an
ultrasound transmitting transducer connected
to an ultrasound generator, a steerable bipolar
electrophysiology catheter incorporating a receiverelectrode at the distal tip. Ultrasound energy was
amplitude-adjusted and transmitted at around 330 kHz.
The lower frequency used in this application achieves
better tissue penetration. Ultrasound pulses generated
from the transmitting transducer traveled through the
chest wall to reach the receiver-electrode with circuitry
to transform the pulses into electrical energy for
myocardial stimulation. The feasibility and safety of
this novel technology was first demonstrated acutely in
animals. 6 In the acute safety study, histological
examination was performed in pigs that were exposed
to continuous ultrasound transmission from the
investigational system for two hours. No mechanical or
thermal bio-effect was identified in the sacrificed
animals. In the acute feasibility study, the receiverelectrode incorporated into a transvascular catheter was
selective positioned and in contact with various heart
chambers of a pig. An external transmitter was then
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placed on the chest wall of the animal, with acoustic
gel used for coupling. Ultrasound energy was then
transmitted through the chest to the receiver, the acoustic
energy was converted to electrical energy, and the
electrodes contacting endocardium stimulated pacing.
The electrode catheter was a modified steerable bipolar
EP catheter with receiver-transducers incorporated near
the tip between the bipolar pacing electrodes. Proximal
connections on the catheter allowed either direct
electrical pacing using a Pacing System Analyzer or
monitoring of the receiver output during ultrasoundmediated pacing. The catheter itself was not directly
involved in or required for ultrasound-mediated pacing.
The acute porcine study demonstrated feasibility of
leadless ultrasound-mediated pacing in five animals at
30 selected sites in the right atrium, right ventricle, left
ventricle, and simultaneously in both left and right
ventricles.6
Following the animal experiments, human studies
were performed. 7 Twenty-four patients were tested
during or after completion of clinical electrophysiology
procedures (Figure 1). A total of 80 pacing sites in the
right atrium, right ventricle, and left ventricle
were tested. The transmit-to-receive distance was
11.3±3.2 cm. Ultrasound-mediated pacing was achieved
at all 80 sites with consistent capture at 77 sites. There
was no adverse event related to ultrasound-mediated
pacing. No patient experienced discomfort during
pacing. This novel technology targeting cardiac
resynchronization therapy was also tested in heart failure
patients.8 In these patients, the acoustic window on the
chest wall that allows efficient ultrasound transmission
was defined and found to be large and sufficient for
subcutaneous implantation of the ultrasound generator,
even after accommodating changes with respiratory
movement and body positioning (Figure 2).
Incorporating this novel technology, the future
implantable leadless pacing system is being designed.
The system includes an ultrasound generator to be
implanted subcutaneously in the acoustic window of
the chest wall and an endocardial receiver-electrode.
The receiver electrode is delivered by a steerable
transvascular catheter to the target heart chamber, and
be detached and implanted onto the endocardium
directly. The receiver and transmitter are programmed
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PSA=pacing system analyzer
Figure 1. Equipment set up of the first study of leadless pacing in humans.

Figure 2. Acoustic window outlined on a reconstruction CT thorax.
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to operate at the same frequency of ultrasound pulses
to avoid external interference. The ultrasound beam will
be optimized and focused onto the receiver electrode in
order to improve the efficacy of energy transfer. The
estimated device longevity will need to be comparable
to that of a conventional pacemaker to make it
commercially viable. The acoustic window suitable for
implant on the patient's chest wall can be localized
preoperatively by conventional echocardiography, a
convenient method that has been shown to predict
efficient ultrasound transmission for leadless pacing.8
There are of course other unresolved issues that
ongoing research is aiming to answer (Table 1).9,10 For
example, many will doubt the long term safety of
continuous ultrasound exposure. Although the lack of
effect of short term ultrasound-mediated pacing has been
shown histologically in animal experiments, tissue
injury secondary to heating with continuous exposure
is theoretically possible. Similar studies on long term
exposure when ultrasound energy was applied in
continuous pacing will address the safety concern.
Another challenge of this technology is environmental
interference which may be ubiquitous. Although precise
formatting and fine tuning of the device can be done,
little is known about its actual performance in the real
world. This is another big safety issue that requires
extensive evaluation. Apart from energy delivery,

transmission of sensed endocardial electrograms is an
important function of a pacing lead. There is so far no
available information on how the sensing circuit of the
future leadless pacemaker is going to operate. As for
the risk of infection, the receiver electrode is small,
embedded in the endocardial followed by complete
endothelialization. It is expected to carry minimal risk
of infection, probably comparable to that of coronary
stents and atrial septal defect occluders.

Alternative Energy Sources
Apart from ultrasound, an alternating magnetic
energy source has been tested in a pig model for leadless
cardiac stimulation. 11 The system consists of two
components, an external transmitter unit and a receiver
unit in contact with the myocardium. The subcutaneous
primary coil generates an alternating magnetic field,
which is converted by the secondary coil inside the heart
to a voltage pulse for pacing stimulation. In the pig
experiment described, an alternating magnetic field of
approximately 0.5 mT was generated by the transmitter
unit in a distance of 3 cm. Voltage pulses with a duration
of 0.4 ms and voltage amplitude of 0.6-1.0 V were
generated. Continuous stimulation of the heart was
demonstrated for 30 minutes. The advantage of this

Table 1. Challenges in the development of leadless pacing technology
• Low efficiency of energy conversion significantly shortens battery longevity
• Problem with consistent capture with a constantly changing pacing window
• Long term safety of prolonged exposure to ultrasound with possible heating effect and tissue injury
• Reliability of a leadless sensing circuit
• Operation and integration of multiple sensing and pacing sites for CRT
• Potential interference from external environment
• Unconventional parasternal site for implanting the pacemaker generator
• Development of a reliable delivery and anchoring system for implanting the endocardial receiver-electrode
• Integration with an implantable defibrillator
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technology is that the efficiency of energy conversion
is relatively high, making device longevity less of a
problem. However, the transmitter coil is of considerable
measurement, 60 mm in diameter, 10 mm in width, and
80 g in weight, while the receiver is 15 mm in length
and 2.5 mm in diameter. Apart from the size of the
device, one major concern of this technology is potential
external interference by environmental magnetic fields.
The long term safety with heat production in the receiver
unit generated with continuous exposure is also
uncertain.
Other wireless energy sources have been used for
stimulation to a limited extent. Radiofrequency energy
transmission is employed in an implantable microstimulator device currently under clinical investigation
for neuro-modulation applications. 12 However, the
implant incorporates a battery requiring frequent
recharging using an inductive link from an external
device. In general, the use of radiofrequency power for
wireless applications in the body has the disadvantages
of being unfocused and having a shallow depth of
penetration. Therefore, it is less efficient than ultrasound
energy. It also requires the transmitter and receiver to
be in close proximity, which essentially precludes its
use for many applications including cardiac pacing.
Ultrasound energy transduction is currently being
used in a clinical application of a wireless sensor.13 In
this application, the receiver is coupled to a pressure
transducer implanted within an abdominal aortic
aneurysm graft for post procedure monitoring after
endovascular repair. The transmitter is an external
device placed on the anterior abdomen to communicate
with the implanted receiver to acquire real time intrasac pressure data.

Future Perspectives
Leadless pacing with ultrasound-mediated energy
was demonstrated in animals and humans in acute
studies. This is by far the most advanced development
with proven technological feasibility. More scientific
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data will be collected from ongoing animal and human
research. With refinement of the technology, challenges
identified will be addressed. Currently, a prototype
device and the implantation equipment are being
developed, and clinical trial of the permanent
implantable system is being planned. At the same time,
various competing technologies are being developed and
evaluated. Although it is not certain if the intended
progress will be accomplished, the favorable result
achieved has aroused significant interest in the field of
cardiac pacing. Many including those in the device
industry are keen to be involved in the development of
a commercially viable leadless implantable pacemaker.
When this is materialized, lead complications and lead
extractions will be minimized.

Summary and Conclusions
Leadless pacing will also open up a new arena
for cardiac resynchronization therapy. Some nonresponders may be converted to responders with
optimization of the left ventricular stimulation site.
Multi-site pacing will no longer be limited by problems
in vascular access or coronary venous anatomy.
Responders may obtain maximal benefit from cardiac
resynchronization therapy with endocardial left
ventricular stimulation.
Although leadless pacing is only in the stage of
proof-of-concept, subcutaneous implantable
defibrillator has been developed and tested in clinical
trial. 14 The preliminary result is encouraging. The
integration of leadless pacemaker and subcutaneous
implantable defibrillator is important as heart failure
patients frequently require cardiac resynchronization
therapy in combination with an implantable defibrillator.
Despite all the advances achieved, much more
work needs to be done before we can accomplish this
major breakthrough in the development of leadless
implantable cardiac devices (Table 2). By that moment,
implanting a pacing lead will become a procedure of
history.
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Table 2. Key issues in development of leadless pacing
• Pacemaker lead complications and failures are important clinical problems.
• The indication of device therapy has been expanded with the advent of cardiac resynchronization therapy;
multiple pacing leads are now implanted in non-bradycardiac heart failure patients.
• Coronary vein anatomy may limit implant success and the clinical response to cardiac resynchronization
therapy. The benefit of cardiac resynchronization therapy may be maximized with endocardial selected-site
and multi-site pacing.
• The idea of energy transfer utilizing an external energy source to stimulate the heart directly was conceived as
the basis of leadless pacing.
• Leadless cardiac stimulation with ultrasound-mediated energy was demonstrated to be feasible in acute studies
in animal models, human patients and heart failure patients.
• Alternative technology of leadless cardiac stimulation with alternating magnetic field for energy induction has
also been successful in an animal experiment.
• The future leadless pacemaker consists of a subcutaneously implanted ultrasound transmitter and an
endocardially implanted receiver. A percutaneous catheter delivery and anchoring system will be used for the
implantation procedure.
• The challenges of leadless pacing include but are not limited to the efficacy of energy conversion, potential
external interference, sensing issues, and long term safety.
• A prototype device for leadless pacing with ultrasound energy has been developed for clinical testing. The first
human implant may be feasible in the near future.
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IL1.
CARDIOVASCULAR RISK FACTORS IN HONG KONG −
AN UPDATE
BMY Cheung
Department of Medicine, The University of Hong Kong, Hong Kong
The Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) was
initiated in 1995-96, when 2895 Hong Kong adults aged 25-75 were recruited
from the general population in Hong Kong using random domestic telephone
numbers. This became a cohort study (CRISPS2) when 1944 participants were
contacted and returned for follow-up in 2000-04. The third round of followup was conducted in 2005-08 (CRISPS3). The overall aim of the cohort study
is to determine the prevalence of cardiovascular risk factors, including
hypertension, diabetes and dyslipidaemia, and to find out the factors that
predispose to the development of these conditions in Hong Kong Chinese.
Previously, we have found that impaired glucose tolerance confers an
overwhelming risk of developing diabetes. We have also traced the natural
history of the development of the metabolic syndrome, which usually starts
with central obesity, followed by dyslipidaemia and then diabetes and
hypertension. We reported that the metabolic syndrome predicts the
development of hypertension and is associated with increased mortality.

prevalence of hypertension increased from 18.1% in CRISPS1 to 39.6% in
CRISPS3. This increase remains significant after adjusting for age. Our findings
confirm the importance of waist circumference in this population, as calculating
the BMI alone may give a false sense of security. The prevalence of
hypertension in Hong Kong is now approaching the level in developed
countries such as the United States. Current efforts are channelled towards
the detection and treatment of hypertension in middle and old age. The linear
rise in the prevalence of hypertension with age means that measures to prevent
hypertension, such as a healthy diet and regular physical activity, should start
early in life. Our analysis of cancer incidence in CRISPS3 suggests a link
between insulin resistance and risk of cancer, so tackling obesity may also be
beneficial in terms of reducing cancer risk.
In CRISPS, DNA has been collected and analysed for association with the
development of cardiovascular diseases. Some of these studies were done in
collaboration with the Guangzhou Number 12 Hospital, where the Guangzhou
Biobank Cohort Study − Cardiovascular Disease Subcohort study is carried
out. One of the first fruits of this collaboration was the identification of a
single nucleotide polymorphism in the APOA5 gene that is common in Chinese
and has an important influence on plasma triglyceride level.

In CRISPS3, the prevalence of general obesity, defined as a body mass index
(BMI) of 27.5 kg/m2 or greater, has not increased since CRISPS1 (16.8% in
CRISPS1, 15.7% in CRISPS2 and 14.9% in CRISPS3). However, the
percentage of the cohort with abdominal obesity, defined as a waist
circumference ≥90 cm in men or ≥80 cm in women, increased significantly
from 25.4% in CRISPS1 to 41.4% in CRISPS3. At the same time, the

IL2.
BIOLOGICAL PACING: PROMISES AND CHALLENGES
MR Rosen
Center for Molecular Therapeutics, Departments of Pharmacology and
Pediatirics, College of Physicians and Surgeons of Columbia University, USA
Electronic pacing has revolutionized the prevention and treatment of lifethreatening bradyarrhythmias during the last half-century. Because electronic
pacemakers are a palliative therapy that might be improved upon, investigators
have begun using gene and cell therapy approaches to effect a cure. Strategies
have coalesced to focus on achieving stable and autonomically responsive
cardiac rhythms in a setting that ultimately would require no implanted
hardware. Most groups working in the area are now using variations on the
HCN (hyperpolarization-activated cyclic nucleotide-gated) family of genes
to create biological pacemakers. Interventions have included the creation of
mutant or chimeric HCN genes as well as co-incorporation of genes to modify
sodium or potassium currents or cell-cell connectivity. In the gene therapy
approach, adenoviral and lentiviral vectors are being explored. In cell therapy
approaches, adult stem cells have been used to carry pacemaker genes to
specific regions of the heart, and embryonic stem cells and induced pluripotent
cells have been used to create pacemakers as well. Challenges to be met include
many aspects of efficacy and safety. These include, but are not limited to,
optimization of the pacemaker construct, understanding more regarding
stability and duration of function and risk of proarrhythmia, and
comprehending the extent to which biological pacing might or might not
represent a clinically relevant supplement to or replacement for electronic
pacing.
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LOSS-OF-FUNCTION IN TOLL-LIKE RECEPTOR 4
RECEPTORS NITRIC OXIDE-MEDIATED RELAXATIONS IN
LEPRdb/db MICE
CF Liang,1 A Xu,1,2 PM Vanhoutte1
1
Department of Pharmacology and Pharmacy and 2Department of Medicine,
The University of Hong Kong, Hong Kong
The present study analyzes the role of toll-like receptor 4 (TLR4), a target for
saturated fatty acids and lipopolysaccharides, in modulating endothelial
function in the mouse aorta. A type-2 diabetes model with double knockout
(DKO) of leptin receptors (Lepr) and TLR4, was obtained by crossing
Leprdb/+ and TLR4-/- mice. Mice were sacrificed and rings [with and without
endothelium] of their aorta were studied for measurement of isometric tension
in a Mulvany-Halpern myograph.

decreased eNOS dimer to monomer ratio and phosphorylation levels, which
was accompanied by phosphorylation of glycogen synthase kinase 3β and
increased expression of β-catenin and NADPH oxidase isoform 4 in wild type
mice aortae and cultured endothelial cells (HUVEC EA.Hy926). The attenuated
relaxations to acetylcholine and the changes in eNOS activity induced by
lipopolysaccharide were inhibited by apocynin, LY294002 (PI3K inhibitor)
and enhanced by LiCl [non specific inhibitor of glycogen synthase kinase
3β].
In conclusion, TLR4 activation decreases eNOS-mediated relaxations by
enhancing oxidative stress produced by NADPH oxidase and resulting in the
stimulation of the glycogen synthase kinase 3β/β catenin cascade. TLR4
inhibition or down-regulation may be a potential target for the treatment of
vascular dysfunction.

Acetylcholine-induced endothelium-dependent relaxations were potentiated
in DKO mice compared with Lepr db/db control mice. The eNOS dimer to
monomer ratio, as well as the basal and acetylcholine-stimulated eNOS
phosphorylation levels were higher in preparations from DKO mice. This
difference in relaxations and eNOS activity [dimer to monomer ratio and
phosphorylation levels] between Leprdb/db and DKO mice was abolished by
apocynin [non-specific NADPH oxidase inhibitor]. Lucigenin-enhanced
chemiluminescence assay suggested a lower basal endothelialproduction of
superoxide anions by NADPH oxidase in DKO mice preparations. Quantitative
PCR results revealed that NADPH oxidase isoform 4 and isoform 1 was
downregulated in DKO mice arteries. Administration of lipopolysaccharide
inhibited acetylcholine-evoked relaxations in wild type mice but not in
TLR4-/- mice. Western blotting analysis revealed that lipopolysaccharide

OC2.
DEFICIENCY OF EP4 RECEPTOR ON BONE MARROWDERIVED CELLS BOOSTED INFLAMMATION AND
ABDOMINAL AORTIC ANEURYSM FORMATION INDUCED
BY ANGIOTENSIN II IN HYPERLIPIDEMIC MICE

Conclusions: Deficiency of EP4 receptor boosted inflammation and AAA
formation induced by angiotensin II in hyperlipidemic mice. This study affirms
the pathophysiologic importance of PGE 2 signaling through EP4 as an
endogenous anti-inflammatory path involved in AAA formation.

EHC Tang,1,2 E Shvartz,1 K Shimizu,1 VZ Rocha,1 C Zheng,1 D Fukuda,1
GP Shi,1 G Sukhova,1 P Libby1
1
Division of Cardiovascular Medicine, Brigham and Women's Hospital,
Harvard Medical School, USA.; 2Department of Pharmacology and Pharmacy,
The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong
Objective: Chronic inflammation during abdominal aortic aneurysm (AAA)
formation contributes to remodeling and eventual weakening of the vessel
wall. Prostaglandin E2 (PGE2), through activation of its receptor EP4, can
mute inflammation. Whether EP4 participates directly in the pathogenesis of
aneurysm remains unknown. We tested the hypothesis that a lack of EP4
receptor on bone marrow-derived cells would increase local inflammation
and enhance the formation of AAA in vivo.
Methods and Results: Hypercholesterolemic low-density lipoprotein receptor
knockout (LDLR-/-) mice transplanted with either EP4+/+ [EP4+/+/LDLR-/-] or
EP4-/- [EP-/-/LDLR-/-] bone marrow received infusions of angiotensin II to induce
AAA. Deficiency of EP4 on bone marrow-derived cells increased the incidence
and severity of AAA, increased monocyte chemoattractant protein-1
(MCP-1), and enhanced infiltration of macrophages and T cells into the AAA
lesions. Lack of EP4 also augmented elastin fragmentation, increased the
number of cells bearing markers of apoptosis, and decreased smooth-muscle
cell accumulation within the AAA lesions.
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IDENTIFICATION OF CHANNELS ON SKELETAL
MYOBLASTS THAT MAY CONTRIBUTE TO ACIDOSISINDUCED ATP RELEASE
L Lu, GR Li, HJ Ballard
Department of Physiology and Institute of Cardiovascular Science & Medicine,
Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Low pH stimulated ATP efflux from skeletal myoblasts, and inhibition of
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) abolished
the acidosis-induced ATP release. CFTR is a chloride channel that has been
reported to mediate ATP efflux from some cell types. Several other chloride
channels or stretch-activated channels are also reported to conduct ATP. In
this study, I aim to identify channels on skeletal myoblasts that are firstly
opened at low pH, and secondly contribute to ATP release.

CaCl2, pH adjusted to 7.3-7.4 with NaOH. The reversal potential of the wholecell current was -28.3±1.34 mV (n=6), which suggests that the current recorded
was the chloride current. The current increased when the medium pH was
reduced from 7.4 to 6.8. A specific inhibitor of CFTR, CFTRinh-172, had no
effect on the current at pH 7.4, but reduced it at pH 6.8; application of forskolin
(10 µM), which elevates intracellular cAMP, produced a similar increase in
whole-cell current to that produced by low pH.
These data suggest that the CFTR Cl− channels were opened at low pH. Further
experiments are in hand to determine which of the other channels contribute
to acidosis-induced ATP release.

RTPCR was used to determine which of the channels reported to conduct ATP
in other cell types were present on skeletal myoblasts. The chloride channels
CFTR, Clcn-2, Clcn-3, Clcn-7, Ca2+ activated chloride channel and volumesensitive outwardly-rectifying channels, and the stretch-activated channels,
Connexin 36, Connexin 43 and Pannexin 3, were expressed on the cells.
Whole-cell patch clamp was performed on skeletal myoblasts using potassiumfree solutions: the pipette (intracellular) solution contained 110 mM
Cs-Aspartate, 20 mM CsCl, 5 mM Na2-Phophocreatine, 1.0 mM MgCl2·6H2O,
10 mM HEPES, 5 mM Cs2-EGTA, 0.1 mM GMP and 5 mM Mg2-ATP, pH
adjusted to 7.2 with CsOH, while the bath (extracellular) solution contained
140 mM NaCl, 5 mM CsCl, 1.0 mM MgCl2, 5.0 mM HEPES and 1 mM

OC4.
DIPEPTIDYL-PEPTIDASE 4 INHIBITOR IMPROVES
ENDOTHELIAL FUNCTION OF SPONTANEOUSLY
HYPERTENSIVE RATS THROUGH ACTIVATION OF GLP-1/
GLP-1 RECEPTOR/AMPK/NO CASCADE
L Liu,1 WT Wong,1 XY Tian,1 J Liu,1 CW Lau,1 YX Wang,2 G Xu,3 A Xu,4,5
KSL Lam,4 ZY Chen,6 X Yao,1 Y Huang1
1
Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, and
School of Biomedical Sciences; Departments of 2Radiology and 3Medicine
and Therapeutics, The Chinese University of Hong Kong; Departments of
4
Medicine and 5Pharmcology and Pharmacy, The University of Hong Kong;
6
Department of Biochemistry, The Chinese University of Hong Kong, Hong
Kong
Objectives Sitagliptin, a highly selective dipeptidyl peptidase 4 (DPP-4)
inhibitor, is a new anti-diabetic drug through inhibiting inactivation and
degradation of glucagon like peptide-1 (GLP-1) and glucose-dependent
insulinotropic polypeptide. This study investigated whether sitagliptin could
protect endothelial function in spontaneously hypertensive rats (SHRs).
Methods SHRs and normotensive WKYs were treated orally with sitagliptin
(10 mg.kg-1.d-1) or vehicle for 2 weeks. Renal blood flow was measured by
magnetic resonance imaging. Intrarenal arteries were suspended in myograph
for force measurement and levels of marker proteins were assayed by Western
blotting. Nitric oxide (NO) production was determined by confocal microscopy
in primary culture of SHR aortic endothelial cells.

J HK Coll Cardiol, Vol 18

Results Relaxation to GLP-1 receptor agonist exendin-4 was impaired in SHR
arteries, which was restored by sitagliptin. The improved relaxation and
sitagliptin- or exendin-4-stimulated rises in [NO]i was reversed by GLP-1
receptor antagonist exendin 9-39, AMPK inhibitor compound C and NOS
inhibitor L-NAME. Overexpression of AMPKα2 further increased while
expression of dominant negative AMPK inhibited phosphorylation of AMPKα
at Thr172 and eNOS at Ser 1177 in response to sitagliptin and exendin-4 in
endothelial cells. 12h incubation with sitagliptin and exendin-4 augmented
endothelium-dependent relaxation (EDR) in SHR arteries, which was
antagonized by exendin 9-39 and compound C. In addition, two-week
administration of sitagliptin improved EDR, increased phosphoryation of
AMPKa and eNOS, up-regulated GLP-1 and GLP-1 receptor in SHR arteries,
and restored renal blood flow in SHR.
Conclusions Sitagliptin improves endothelial function in hypertensive rats
by restoring NO bioavailability via AMPK/eNOS activation. Stimulating
GLP-1/GLP-1 receptor signaling pathway could be another therapeutic option
in controlling hypertension-related vascular events.
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INTERMITTENT HYPOXIA INDUCES PARADOXICAL
CARDIO-PROTECTIVE EFFECTS IN AN ANIMAL MODEL
VIA HEME OXYGENASE-1 UPREGULATION
Q HAN,1 SC Yeung,1 MSM Ip,1,2 JCW Mak1-3
Department of Medicine; 2Reserach Centre of Heart, Brain, Hormone and
Healthy Aging; 3Department of Pharmocology & Pharmacy, The University
of Hong Kong, Hong Kong
1

Background: Obstructive sleep apnea (OSA), with intermittent hypoxia during
sleep, is increasingly recognized as an independent risk factor of cardiovascular
diseases (CVD). Oxidative stress and inflammation are pathogenic mechanisms
in CVD, but majority of studies have focused on the systemic status. Hemeoxygenase-1 (HO-1) is a stress inducible protein and catalyzes rate-limiting
step of degradation of cellular heme into free iron, carbon monoxide (CO)
and biliverdin/bilirubin, all of which may exert anti-oxidative and antiinflammatory effects. The aim of this study was to use an animal model to
evaluate oxidative stress and inflammation in response to intermittent hypoxia
(IH) with or without diet-induced hyperlipidemia, with special reference to
any difference in the systemic and cardiac response, and the mechanistic
pathways involved.
Methods: Male Sprague-Dawley rats were divided into four groups: regular
chow diet or high fat high cholesterol (HFHC) diet plus intermittent air (IA)
or IH treatment, and rats were sacrificed at 2 or 4 weeks. Serum and cardiac
levels of oxidative and pro-inflammatory markers were assayed with ELISA
and semi-quantitative PCR, the expression of HO-1 and activation of signaling
pathways in the heart were analyzed by Western blot.

Results: IH and HFHC diet alone or together caused time-dependent elevation
in serum malondialdehyde (MDA) and CINC-1 and reduction in serum
adiponectin levels. In contrast, elevation of cardiac adiponectin level and
suppression of the cardiac levels of oxidative and pro-inflammatory markers
were seen, accompanied by upregulation of expression of cardiac HO-1 at 4
weeks when cardiac activation of ERK and Akt signaling pathways were also
observed.
Conclusions: Oxidative stress and inflammation resulted from IH and
hyperlipidemia may serve as a potential mechanism underlying OSA-related
CVD. However, the upregulation of HO-1 expression may exert a local
protective function in the heart via activation of ERK and Akt signaling
pathway from systemic oxidative and inflammatory insults.
Acknowledgement: This research is supported by Hong Kong RGC General
Research Fund (HKU 771908M).

OC6.
BETA1 SUBUNIT-DEPENDENT MODULATION OF BK
CHANNEL BY MEMBRANE CHOLESTEROL
W Wu, CP Lau, HF Tse, GR Li
Department of Medicine, The University of Hong Kong, Queen Mary Hospital,
Hong Kong
Background: The large conductance Ca2+-activated K+ (BK, or slo) channels
are ubiquitously expressed in different tissues without (brain, liver, etc) or
with (smooth muscle and heart) regulatory beta-subunit, and play an important
role in regulating various physiological processes such as cell excitability,
hormone secretion, vascular activity, etc. Recent studies have shown that
membrane cholesterol is a major regulator of several potassium channels
including Kir and Kv1.5 channels. However, the regulation of BK channels
by cholesterol is not fully understood.
Methods: Whole cell BK current and BK single channel current were recorded
in whole-cell patch clamp mode and cell-attached single channel recording,
respectively, in HEK 293 cells stably expressing Maxi-K with beta1-subunit.
Western Blotting was performed to detect the protein expression of BK channel.
Results: We found that whole-cell BK current was significantly suppressed
with cholesterol enrichment by cholesterol saturated methyl-beta-cyclodextrin
(MβCD), whereas cholesterol depletion by MβCD had no effect on the current
amplitude. Low-density lipoprotein (LDL), a class of lipoprotein particles
carrying cholesterol around the body, also largely decreases BK current. Single
channel recording showed that cholesterol enrichment significantly reduced
the open probability of BK channel, suggesting that cholesterol increase likely
decreases the membrane channel number. In the opposite, in the cells stably
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expressing BK channel without beta1-subunit, cholesterol-saturated-MβCD
has no significant effect on the current amplitude of BK channels. Western
Blotting data shows that BK channel α subunit expression was reduced by
cholesterol-saturated-MβCD or LDL while the β1 subunits expression did
not alter. However, both á and b1 subunits expression of BK channel in cultured
HCASMCs (Human Coronary Artery Smooth Muscle Cells) was suppressed
by cholesterol-saturated-MβCD or LDL.
Conclusion: Our results demonstrate the important evidence that BK channels
exhibit beta1-subunit-dependent responses to cholesterol. The enrichedcholesterol and LDL reduce the activity of BK channels co-expressed with α
and β1 subunit, which may at least in part accounts for the occurrence of
hypertension in patients with high plasma cholesterol level, since both of α
and β1 subunit transcripts are abundant in vascular smooth muscle.
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LIPOCALIN-2 DEFICIENCY PROTECTS HEARTS AGAINST
ISCHEMIA/REPERFUSION INJURY
B Yang,1 A Xu,1,2 PM Vanhoutte,1 HF Tse,2 Y Wang1
Department of Pharmacology and Pharmacy, 2Department of Medicine, Li
Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
1

Lipocalin-2 is a pro-inflammatory adipokine causally involved in the
development of obesity-associated metabolic and vascular diseases. Clinical
evidences suggest that there are close associations between circulating levels
of lipocalin-2 and cardiac dysfunction. However, little is known about the
detailed roles of lipocalin-2 in regulating pathophysiological functions of the
heart. The present study has used a Langendorff system to evaluate the heart
function of mice lacking lipocalin-2. The results demonstrate that in response
to a 20-min global ischemia injury and during the 60-min reperfusion, hearts
from lipocalin-2 knockout mice (Lcn2-KO) show a better recovery and
improved myocardial contractile functions, compared to those littermates with
normal lipocalin-2 expressions. These phenomena can be observed in mice
under both standard chow and high fat feeding conditions. Deficiency of
lipocalin-2 significantly reduced heart infarct size and lactate dehydrogenase
release. These protective functions are partly attributed to the enhancement of
mitochondrial respiratory chain activities in Lcn2-KO mice. Furthermore,
lipocalin-2 treatment is able to block the recovery of heart function during
ischemia/reperfusion injury and acutely damage the mitochondrial functions.
In summary, the results support a potential role of lipocalin-2 in the
pathogenesis of obesity-related cardiac disorders.

OC8.
UP-REGULATION OF HEME OXYGENASE-1 IMPROVES
E N D O T H E L I A L F U N C T I O N S B Y I M PA I R I N G
ENDOTHELIUM-DEPENDENT CONTRACTIONS AND
ENHANCING ENDOTHELIUM-DEPENDENT
HYPERPOLARIZATIONS
Z Li, PM Vanhoutte
Department of Pharmacology & Pharmacy, The University of Hong Kong,
Hong Kong
Objective: Heme oxygenase (HO) attenuates the production of reactive oxygen
species (ROS) through its ability to degrade heme and produce carbon
monoxide (CO), biliverdin/ bilirubin, and to release free iron. Up-regulation
of HO lowers blood pressure in animals. However, the underlying mechanism
is still unknown. The present study was designed to investigate whether or
not up-regulation of HO by the pharmacological agent hemin improves
endothelial function in arteries of the spontaneous hypertensive rat (SHR).
Methods: 36 weeks old SHR were divided into two groups. One group received
an intraperitoneal injection of hemin (50 mg•kg-1, 24 hours before sacrifice)
while; the control group was injected with normal saline. Rings of aorta and
mesenteric arteries were suspended in organ chambers for isometric tension
recording. The intracellular reactive oxygen species (ROS) concentration was
measured by confocal microscopy. The release of prostanoids was measured
by enzyme immunoassay. Expression of HO-1, cyclooxygenase (COX) and
prostaglandin I2 synthase in the aorta was measured by Western blotting.

J HK Coll Cardiol, Vol 18

Results: HO-1 protein expression was significantly higher in the hemin
treatment group than in controls, implying that HO-1 is induced by hemin.
This up-regulation of HO-1 resulted in an impairment of both acetylcholineand A23187-induced endothelium-dependent contractions. A lower expression
level of COX-1, a lower intracellular ROS production and a lower release of
prostaglandin F1α (the major stable metabolite of prostacyclin) were observed
in the hemin treatment group as compared to the controls. The sensitivity of
thromboxane-prostanoid (TP) receptors to prostacyclin and iloprost
(prostacyclin analog) were significantly attenuated in hemin-treated rats.
Moreover, hemin treatment potentiated acetylcholine-evoked relaxations in
mesenteric arteries in the presence of L-NAME and indomethacin, implying
a facilitation of endothelium-dependent hyperpolarizations. These enhanced
EDHF response were abolished by ouabain (Na+-K+-ATPase blocker) and
barium chloride (Kir channel blocker), indicating an involvement of Na+-K+ATPase and Kir channel.
Conclusions: Up-regulation of HO-1 improves endothelial function by
attenuating endothelium-dependent contractions as well as potentiating
endothelium-dependent hyperpolarizations. The impairment of endotheliumdependent contractions can be explained by an impairement of the expression
of COX-1 resulting in the attenuation of the production of ROS and
vasoconstrictor prostaglandins combined with a reduced TP receptor
sensitivity. The enhancement of endothelium-dependent hyperpolarizations
is related to Na+-K+-ATPase and Kir channel.
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RESTORATION OF BLUNTED INSULIN RELEASE AND
[Ca 2+ ] i CHANGES BY SIMVASTATIN OF ISOLATED
PANCREATIC ISLETS OF LANGERHANS OF OBESE/
DIABETIC (db+/db +) MICE
ALS Au, 1 CCW Poon, 1 Q Zhang, 1 GPH Leung, 2 SK Kong, 3 HP Ho, 4
YW Kwan1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese
University of Hong Kong; 2Department of Pharmacology and Pharmacy,
Faculty of Medicine, The University of Hong Kong, 3School of Life Sciences,
Faculty of Science, The Chinese University of Hong Kong and 4Department
of Electronic Engineering, Faculty of Engineering, The Chinese University
of Hong Kong, Hong Kong
Background: One of the factors responsible for Type 2 diabetes mellitus
development is a decline in pancreatic islets β-cells secretory functions.
Diabetic patients with dyslipidemia are now receiving HMG CoA reductase
inhibitors (so-called statins). However, there is no consensus on whether
statins consumption can improve diabetic conditions in patients.
Methodology: The pancreatic islets of age-matched (female; ~6 month-old)
lean/control (db+/m+) and obese/diabetic (db+/db+) of C57BL/KsJ mice were
isolated using collagenase; single pancreatic b-cells of both strains of mice
were further isolated by trypsin. Effects of simvastatin (a HMG CoA
reductase inhibitor) (10 nM, 24 hr) and L-phenylalanine (an allosteric
activator of CaR) (10 mM, 24 hr) on protein expression of CaR, SNARE
proteins (VAMP-2 and syntaxin) and glucokinase (GCK) were compared.
Glucose (15 mM)- and carbachol (500 µM)-elicited [Ca2+]i changes of single
pancreatic islet β-cells, with and without simvastatin incubation, were
measured. Glucose (5 and 15 mM)-induced insulin secretion (GIIS) was

determined (ELISA).
Results: A lowered protein expression of CaR and a smaller magnitude of
glucose (15 mM)- and carbachol (500 µM)-induced [Ca2+]i changes were
detected in pancreatic islets/pancreatic β-cells of db+/db+ mice compared to
db+/m+ mice, which was restored by simvastatin and L-phenylalanine. An
attenuated glucose (5 and 15 mM)-induced insulin release was measured in
pancreatic islets of db +/db + mice and the suppressed glucose (15 mM)induced insulin release was partially restored by simvastatin and
L-phenylalanine. A lowered expression of GCK (but not SNARE proteins)
was detected in pancreatic islets of db+/db+ mice which was not modified
by simvastatin.
Conclusions: The blunted GIIS of isolated pancreatic islets of db+/db+ mice
is related to an attenuated CaSR expression and the redundancy of its
associated Gq/11 receptor pathways. The "enhanced" protein expression of
CaSR and the improvement of glucose-/carbachol-elicited [Ca2+]i changes
by simvastatin is probably responsible for the restoration of the attenuated
GIIS of the pancreatic β-cells of db+/db+ mice.
Acknowledgements: This project was financially supported by GRF Grant
(to YWK) (Reference number: 2140565).

P2.
INVOLVEMENT OF CFTR IN ATP RELEASE FROM
CONTRACTING SKELETAL MUSCLE IN ANAESTHETISED
RATS
WS Cai, FK Ng, HJ Ballard
Department of Physiology and Institute of Cardiovascular Science &
Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Hong Kong
Contracting skeletal muscle releases ATP into the interstitial space where it
is subsequently broken down to adenosine by the action of ecto-5'nucleotidase. Both ATP and adenosine are vasodilators that contribute to
the exercise hyperaemia. However, the mechanism for the release of ATP
from muscle during exercise remains unknown. Cystic fibrosis
transmembrane conductance regulator (CFTR) is a possible channel for ATP
release: this study was performed to investigate whether CFTR was involved
in the ATP release from muscle during exercise.

of 40 mins. In the test group of rats, KT5720, a protein kinase A inhibitor
which prevents activation of CFTR, was administered between the two bouts
of contractions; in the control rats, no drug was given.
In the control rats, interstitial adenosine increased from 0.57±0.08 to
1.61±0.40 µM during the first contraction bout and from 0.65±0.13 to
1.51±0.44 µM in the second contraction bout, whilst AMP increased from
0.40±0.06 to 1.14±0.29 µM during the first contraction bout and from
0.46±0.09 to 1.07±0.31 µM in the second contraction bout; neither the force
nor the interstitial adenosine and AMP differed significantly between the
two bouts of contraction. Administration of KT5720 did not alter the resting
interstitial concentrations of adenosine or AMP, but reduced the contracting
adenosine concentration from 1.81±0.21 to 0.90±0.16 µM and the contracting
AMP concentration from 3.76±0.57 to 2.25±0.28 µM.
These results suggested that the CFTR may have been involved in the ATP
release from skeletal muscle during exercise hyperaemia.

Experiments were performed in rats anaesthetised with sodium
pentobarbitone and breathing spontaneously. A microdialysis probe was
placed in one gastrocnemius muscle and samples of interstitial microdialysate
were analysed by HPLC for the ATP breakdown products, AMP and
adenosine. An electrode was placed on the sciatic nerve, which was stimulated
to induce two bouts of muscle contractions, separated by a recovery period
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A NEWLY-DERIVED SMALL SYNTHETIC COMPOUND
ALLEVIATED VENTRICULAR FIBRILLATION IN A PIG
MODEL WITH CHRONIC MYOCARDIAL INFARCTION AS
REVEALED BY OPTICAL MAPPING

In conclusion, C11 alleviated VF in our ex vivo pig heart model with chronic
myocardial infarction. Further investigation in the ionic properties of C11
will be of worthy to further dissect the underlying mechanism of function
posing potential use of C11 in clinical prospect.

YC Chan1, YK Lee1, KM Ng1, WH Lai1, D Yang2, HF Tse1,3, CW Siu1,3
Cardiology Division, Department of Medicine, Queen Mary Hospital;
2
Department of Chemistry; 3Research Center of Heart, Brain, Hormone and
Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong
Kong, Hong Kong

1

The electrophysiological hallmark of cells and tissues isolated from failing
hearts is prolongation of action potential duration (APD), resulted from
down-regulation of repolarizing K+ currents and/or alterations in depolarizing
Na+ and Ca2+ currents, which predisposes the failing heart to lethal ventricular
tachyarrhythmia (ventricular tachycardia (VT) and ventricular fibrillation
(VF)). C11, a small synthetic Cl- channel, exhibits membrane-repolarizing
power. Therefore, we hypothesize C11 corrects the delayed repolarization
and shortens APD at cellular level, thus modifying ventricular
arrhythmogenic substrate at whole heart level. First, we demonstrated APD
reduction upon C11 application (30 µM) at 37 oC to isolated guinea pig
ventricular cardiomoyocytes with patch-clamp experiments in whole cell
configuration.
To examine whether C11 works in disease model, pig hearts with chronic
myocardial infarction (MI) were optically mapped. Electrocardiograms
(ECGs) and the optical mapping signals with optical timing maps displayed
the attenuation of ventricular fibrillation (VF) to ventricular tachycardia
(VT) in the presence of C11 (30 µM).

P4.
VASCULAR MODULATION EFFECT OF GINSENG
EXTRACTS
GHH Chan,1 SW Chan,2 CW Lau,3 Y Huang,3 PYK Yue,1 RNS Wong1
Department of Biology, Hong Kong Baptist University; 2Department of
Applied Biology and Chemical Technology, Hong Kong Polytechnic
University; 3School of Biomedical Sciences, The Chinese University of Hong
Kong, Hong Kong

1

Background: It is known that endothelial damage is the primary cause of
the vascular complications of diabetes mellitus. Moreover, the endothelial
damage is usually not reversible.
Materials and methods: In the present study, we examine the effects of
ginseng extracts (PPD and PPT) on acetylcholine-induced endothelium
dependent vasorelaxation pre-contracted with phenylephrine. Studies were
performed in adult Sprague-Dawley male rats and the responses were
examined in vitro using isolated thoracic aortic rings.
Result: Severe impairment of vasorelaxation was found in diabetic group
(62.4% of control in maximum dosage of ACh-induced vasorelaxation) while
the groups fed with ginseng extracts restored the vasorelaxation (no
significant difference with control). Blood profile exhibited that the ginseng
extracts could not reduce blood glucose and blood cholesterol level caused
by diabetes mellitus. However, ginseng extract PPD improved nitric oxide
(in terms of nitrite) production stimulated by acetylcholine.
Conclusion: Ginseng may have vascular protective effect on diabetic
condition.
Acknowledgement: The funding support is provided by the Collaborative
Research Fund (HKBU 1/06C) of Research Grant Council of HKSAR.
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NAHS RELAXES RAT CEREBRAL ARTERIES THROUGH
INHIBITING L-TYPE CALCIUM CHANNEL
WS Cheang,1 XY Tian,1 WT Wong,1 SY Tsang,2 CW Lau,1 X Yao,1 Y Huang1
Institute of Vascular Medicine and School of Biomedical Sciences,
2
Department of Biochemistry, The Chinese University of Hong Kong, Hong
Kong
1

Objectives: H2S may act through the opening of ATP-sensitive K+ channels
or 4-aminopyridine-sensitive voltage-gated K + channels to cause
vasodilatation, depending on the type of blood vessels. It is however unclear
how H2S acts on cerebral arteries. The present study investigates whether
NaHS, a H2S donor, inhibits voltage-sensitive Ca2+ channels and thus relaxes
cerebral arteries.
Methods: Middle cerebral arteries of Sprague-Dawley rats were suspended
in wire myograph or pressurized myograph for measurements of vascular
reactivity under isometric or isobaric conditions. Single myocytes were
enzymatically isolated from the rat cerebral arteries for measuring wholecell L-type Ca2+ currents by a patch-clamp method. Ca2+ movement in isolated
cerebral arteries was determined using a fluo-4 fluorescence dye under
confocal microscope.
Results: NaHS relaxed both phenylephrine and 60 mM KCl pre-contracted
rat cerebral arteries with the same potency. The relaxations were unaffected
by several K+ channel blockers, NOS inhibitor NG-nitro-L-arginine methyl
ester, nor cyclo-oxygenase inhibitor indomethacin. H2S precursor L-cysteine
induced dilatation in cerebral arteries, which was inhibited by cystathionine
γ-lyase inhibitor DL-propargylglycine. NaHS concentration-dependently

inhibited CaCl 2-induced contraction in Ca 2+-free Krebs solution. NaHS
reduced the amplitude of L-type Ca2+ currents in isolated myocytes and
directly inhibited Ca2+ influx in rat cerebral arteries. NaHS also caused
relaxation of myogenic tone in cerebral arteries under pressurized condition.
Conclusions: NaHS causes relaxations, independent of K+ channel activation,
and suppresses CaCl2-induced contractions in rat cerebral arteries. It reduced
L-type Ca2+ currents in myocytes and inhibited Ca2+ influx in rat cerebral
arteries. These suggest that H2S relaxes cerebral arteries primarily through
inhibiting Ca2+ influx via L-type Ca2+ channels.

P6.
E X P R E S S I O N O F T R P C H A N N E L S I N A RT E R I A L
BARORECEPTOR NEURONS
OC Lau, CO Wong, Y Huang, X Yao
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong
Kong
TRP channel is a superfamily of non-selective cation channels that can be
divided into seven subfamilies: TRPA, TRPC, TRPM, TRPML, TRPN, TRPP,
and TRPV. Many TRP isoforms have been reported to be sensors for diverse
source of external and/or internal stimuli. Although still under debating,
TRPC1, -C5, -C6 are suspected to be responsive to direct membrane stretch;
TRPV1, -V4 are suggested be activated by stretch-induced cytoskeleton
displacement and/or flow stimuli; TRPM4, -V4, -C6 are reported to be
activated by stretch-sensitive cytosolic signaling molecules.

The results demonstrated that TRPC1, C5, C6, V4 are expressed in the aortic
baroreceptor nerver terminal which is located on the aortic arch, along the
nerve fibre (aortic depressor nerve) and in the ganglion region (nodose
ganglion). Moreover, western blotting and RT-PCR using isolated rat nodose
ganglion also showed the expression of some TRP channels. In summary,
our study suggests that TRP channels could be mechanosensor involved in
blood pressure detection in the arterial baroreceptor neurons.

Arterial baroreceptors are the mechanosensor to detect blood pressure. Upon
changes in arterial blood pressure, the baroreceptive nerve terminal on the
blood vessel adventitia will be activated, resulting in action potentials which
propagate to the cardiovascular control centre in the brain through its afferent
nerve. However, the molecular identity of the baroreceptor mechanosensors
is not well understood.
There are two major baroreceptors, aortic and carotid baroreceptors. In the
present study, immunohistochemistry was employed to explore the
expression of mechanosensitive TRP isoforms in the rat aortic baroreceptor.
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ASSOCIATION OF A GENETIC VARIANT IN THE
APOLIPOPROTEIN A5 GENE WITH THE METABOLIC
SYNDROME IN CHINESE
KL Ong, 1 CQ Jiang, 2 B Liu, 2 YL Jin, 2 AWK Tso, 1 S Tam, 3 KS Wong, 4
B Tomlinson, 4 BMY Cheung, 1 JM Lin, 2 XJ Yue, 2 KSL Lam, 1 TH Lam, 5
GN Thomas6
1
Department of Medicine, The University of Hong Kong, Hong Kong;
2
Guangzhou No. 12 Hospital, China; 3Department of Clinical Biochemistry,
Queen Mary Hospital, Hong Kong; 4 Department of Medicine and
Therapeutics, The Chinese University of Hong Kong, Hong Kong;
5
Department of Community Medicine and School of Public Health, The
University of Hong Kong, Hong Kong; 6Public Health, Epidemiology and
Biostatistics, University of Birmingham, UK

Results: The minor allele of rs662799 was significantly associated with
higher odds for the MetS in Hong Kong subjects at both baseline (OR=1.47,
P=0.00082) and follow-up (OR=1.30, P=0.010). A similar association was
found in Guangzhou subjects (OR=1.27, P=0.0041). In a pooled sample of
Hong Kong subjects at follow-up and Guangzhou subjects, this SNP was
also associated with HDL and LDL cholesterol (P<0.001 and 0.010
respectively). All these associations disappeared after further adjusting for
plasma triglycerides (P>0.05). In a meta-analysis of 6 studies, the combined
OR (95% CI) was 1.38 (1.25-1.52) for the TC + CC genotype compared to
the TT genotype (P<0.00001).
Conclusion: The association of -1131T>C polymorphism in APOA5 with
the MetS was mainly due to its strong effect on plasma triglycerides. Further
studies are needed to assess the utility of this genetic marker in risk
stratification.

Introduction: We previously reported that the single nucleotide
polymorphism (SNP) rs662799 (-1131T>C) in the apolipoprotein A5 gene
(APOA5) was an important determinant of plasma triglycerides in both Hong
Kong and Guangzhou Chinese. We, therefore, investigated the association
of SNPs in APOA5 with the metabolic syndrome (MetS) in the Hong Kong
and Guangzhou Chinese.
Methods: MetS was defined according to the consensus criteria proposed
jointly by several organizations in 2009. Five tagging SNPs were genotyped
in 1330 unrelated subjects from the Hong Kong Cardiovascular Risk Factor
Prevalence Study cohort with follow-up after a median interval of 6.4 years.
1952 subjects from the Guangzhou Biobank Cohort Study-Cardiovascular
Disease Subcohort were used to replicate the findings.

P8.
ROSIGLITAZONE UPREGULATES ENDOTHELIAL
E X P R E S S I O N O F E N D OT H E L I N B R E C E P TO R
A N D AT T E N UAT E S E N D O T H E L I N - 1 - I N D U C E D
VASOCONSTRICTION
XY Tian,1 WT Wong,1 J Tian,2 P Zhang,2 N Wang,2 Y Huang1
1
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong, Hong Kong; 2Institute of Cardiovascular
Science, Peking University, China

A192621. In vivo treatment with rosiglitazone also attenuated the ET-1induced vasoconstrictions and increased the ET BR expression without
affecting the expression of ETAR in mouse aortas and mesenteric arteries.
Conclusions: These results demonstrated that rosiglitazone attenuated ET1-induced vasoconstriction through the upregulation of endothelial ETBR,
which is a PPAR gamma direct target. (Supported by the NSFC and RGC)

Objectives: Thiazolidinediones improve insulin resistance and endothelial
dysfunction. However, the mechanisms underlying the vasoprotective effects
of thiazolidinediones remain to be fully elucidated. The present study aimed
to investigate the molecular mechanism for the anti-vasoconstrictive effects
of peroxisome proliferator-activated receptor-gamma (PPARgamma) ligand
rosiglitazone in response to endothelin (ET)-1.
Methods: Mouse aortas were treated with rosiglitazone for 24 hours, and
ET-1-induced vasoconstriction was assessed by wire myography. The results
showed that rosiglitazone attenuated ET-1-induced contraction in mouse
aortas; this effect was abolished by ET-B receptor (ET BR) antagonist
A192621, NO synthase inhibitor (L-NAME), and by the removal of
endothelium. Western blotting, and immunohistochemistry showed that
rosiglitazone upregulated expression of ETBR in mouse aortas. Rosiglitazone
also enhanced selective ETBR agonist sarafotoxin 6c-induced vasodilatations
in mesenteric resistance arteries which were abolished by L-NAME or
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CHARACTERIZATION OF MULTIPLE ION CHANNELS IN
HUMAN INDUCED PLURIPOTENT STEM CELLS-DERIVED
MESENCHYMAL STEM CELLS
J Zhang, YC Chan, HF Tse
Department of Medicine, The University of Hong Kong, Hong Kong
Our recent studies demonstrated that functional mesenchymal stem cells
(MSCs) can be derived from human induced pluripotent stem cells (iPS)
which can be used as an alternative source of stem cells for cardiac repair.
However, transplantation of iPS-MSC with undesirable electrical ionic profile
into human myocardium can be potentially lethal. Here, we characterized
the electrophysiological properties of iPS-MSCs with comparison to that of
bone-marrow (BM) derived MSCs, since human iPS-MSCs showed similar
phenotype and expression of surface markers for MSCs as BM-MSCs.

and Kv4.3 (for the transient outward potassium current, Ito), but not Kv1.4
and Kv4.2 (for Ito). Patch clamp experiments were conducted to verify the
existence of functional ion channels, five types of currents (BKCa, IKDR, IKir,
IKCa and ICl) were found in human iPS-MSCs, but not the three (INa.TTX, ICa.L
and Ito) reported in BM-MSCs.
We conclude that although human iPS-MSC and BM-MSC showed similar
phenotype, they have different ionic channel profile. The functional
implication for these differences in the ionic profile merits further
investigation.

The expression of various common ion channels for sodium (Na+), potassium
(K+), calcium (Ca2+) and chloride (Cl−) in human iPS-MSCs were examined
by reverse transcription-polymerase chain reaction (RT-PCR). Those
functional ion channels identified by RT-PCR were confirmed by wholecell patch clamp technique. RT-PCR revealed the molecular identities
(mRNAs) of some ion channels and their possible existence in human iPSMSCs, including KCa.1.1 (responsible for the big conductance Ca2+-activated
K+ current, BKCa), Kv10.1 (for the delayed rectifier K+ current, IKDR), Kir2.1
and Kir2.3 (for the inwardly-rectifying K+ current, IKir), KCa3.1 (for the
intermediate conductance Ca2+-activated K+ current, IKCa), Clcn3 (for the
chloride current, ICl), SCN9A (for the tetrodotoxin-sensitive sodium current,
INa.TTX), CACNA1C (for the nifedipine-sensitive L-type Ca2+ current, ICa.L)

P10.
EXPRESSION OF TRPC AND TRPM CHANNELS IN HUMAN
ATRIAL MYOCYTES
YH Zhang, CP Lau, HF Tse, GR Li
Department of Medicine, LKS Faculty of Medicine, The University of Hong
Kong, Hong Kong

information TRPC1, TRPC3, and TRMP7 channels are present in human
atrial myocytes. Activation of TRP channels likely contribute to the genesis
of human atrial fibrillation, and therefore TRP channels may be a target for
the development of anti-atrial fibrillation approach.

Generation of cardiac arrhythmias, especially human atrial fibrillation
underlying mechanisms, is not fully understood. Recent studies have
demonstrated that transient receptor potential (TRP) channels play important
roles in the regulation of physiological and pathological cellular function.
Little information is documented about TRP channels in human hearts. The
present study was designed to investigate the expression of TRP channels in
human atrial myocytes using whole-patch voltage clamp and molecular
biological approaches. It was found that the previously reported background
nonselecteve cation current was inhibited by the TRPC channel blocker La3+
in a concentration dependent manner (IC 50 =46 µM), suggesting the
contribution of TRPC channels. In addition, we recorded a currents that is
sensitive to inhibition by divalent cations, e.g. Mg 2+, Ni2+, Ba 2+, etc. The
current is enhanced by removing intracellular Mg2+ or extracellular Mg2+
ion, but blocked by Ni2+ or Ba2+. This divalent cation-sensitive current was
inhibited by 2-aminoethoxydiphenyl borate (2-APB, IC50=32 µM), increased
when the bath medium pH was reduced from 7.3 to 4.0. These properties
are similar to those of TRPM7 channels. RT-PCR and Western blot analysis
revealed that mRNAs and proteins of TRPC1, TRPC3, and TRPM7 were
significant in human atrial myocytes. These results demonstrate the novel
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ENDOTHELIAL NOS-INDEPENDENT RELEASE OF NITRIC
OXIDE IN THE AORTA OF THE SPONTANEOUSLY
HYPERTENSIVE RAT
YZ Zhao, SWS Leung, PM Vanhoutte
Department of Pharmacology & Pharmacy, The University of Hong Kong,
Hong Kong
Objective: In the aorta of male spontaneously hypertensive (SHR), but not
in that of normotensive Wistar-Kyoto (WKY) rats the endothelium inhibits
the contraction to phenylephrine despite the presence of indomethacin
(inhibitor of cyclooxygenase) and L-NAME (inhibitor of nitric oxide
synthase (NOS). The present studies were designed to examine the
mechanism underlying this endothelium-dependent inhibition in the SHR
aorta.
Methods: Aortic rings, with and without endothelium, of male SHR and
WKY of age (12 to 22 weeks and 38 to 48 weeks old) were suspended in
organ chambers for the measurement of isometric tension. The preparations
were incubated with indomethacin (10 -5 M) and L-NAME (10 -4 M) to
eliminate the effect of endogenous prostanoids and nitric oxide (NO)
produced by nitric oxide synthases (NOS), respectively. After incubation
with carboxy-PTIO (nitric oxide scavenger, 3 x 10-4 M) for five minutes or
ODQ (guanylyl cyclase inhibitor, 10 -5 M) for 30 minutes, the rings were
contracted with increasing concentrations (10-9-10-6M) of phenylephrine.
Sodium nitrite (10-7-10-2.5M) was used to relax the rings during the contraction
to phenylephrine.

Results: Contractions to phenylephrine were smaller in SHR aortae with
endothelium than in those without endothelium of both either. The inhibitory
effect if the endothelium was larger in preparations from 38-48 weeks than
those from 12-22 weeks old SHR. The endothelium-dependent difference
in contraction to the alpha-adrenergic agonist was prevented by carboxyPTIO or ODQ. The contraction of aortic rings with and without endothelium
of 12-22 weeks or 38-48 weeks old WKY were comparable were not affected
by either carboxy-PTIO or ODQ. Sodium nitrite relaxed SHR aortae with or
without endothelium to the same extent and this relaxation was eliminated
by ODQ. Otherwise, the contraction evoked by KCl has the same difference
in aorta of SHR or WKY with and without endothelium.
Conclusion: In the SHR aorta, there is an endothelium-dependent release
of nitric oxide which is not produced by NOS. This NOS-independent nitric
oxide release, which is only seen in preparations from hypertensive animals
and augments with aging when endothelial dysfunction develops. Nitrite
may be the source of the NOS-independent nitric oxide since its dilator
effect is comparable in rings with and without endothelium of either
normotensive or hypertensive animals.

P12.
ACTIVATION OF NICOTINIC RECEPTORS CONTRIBUTES
TO ACETYLCHOLINE-INDUCED ENDOTHELIUMDEPENDENT RELAXATIONS IN THE AORTA OF THE
SPONTANEOUS HYPERTENSIVE RAT
Q Zou, PM Vanhoutte
Department of Pharmacology & Pharmacy, The University of Hong Kong,
Hong Kong
Acetylcholine causes both endothelium-dependent relaxations and
contractions in the rat aorta. Both muscarinic (mAChRs) and nicotinic
(nAChRs) acetylcholine receptors are expressed in endothelial cells. It is
generally accepted that mAChRs [of the M3-subtype] are responsible for
both endothelium-dependent relaxations and contractions evoked by
acetylcholine. To study the expressions of acetylcholine receptors in rat aorta,
PCR primers for different subunits of nAChRs and mAChRs were designed.
To study whether or not nAChRs are involved in endothelium-dependent
relaxations evoked by the cholinergic transmitter, 36 weeks old spontaneous
hypertensive rats (SHR) and Wistar Kyoto (WKY) rats, and 64 weeks old
WKY rats were used. Rings with endothelium were suspended in organ
chambers for isometric tension recording. Quiescent rings were incubated
with vehicle, mecamylamine (nAChRs inhibitor, 10-4M), atropine (mAChRs
inhibitor, 10 -5M), or mecamylamine plus atropine. The concentration of
mecamylamine and atropine was the lowest concentration that gave the most
significant inhibitory effect in organ chamber experiments. All the rings
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were incubated with indomethacin (non-selective cyclooxygenase inhibitor,
10-5 M) to prevent endothelium-dependent contractions. After 40 minutes of
incubation, the rings were contracted with phenylephrine (10-5M) and then
relaxed with cumulatively increasing concentrations of acetylcholine (10-9
to 10-5M). The PCR results revealed that α2, 3, 4, 5, 6, 7, 9, 10 subunits of
nAChRs and M1-M5 subunits of mAChRs were expressed in 36 weeks old
SHR aorta. The organ chamber experiments demonstrated that in both SHR
and WKY aortae, acetylcholine-induced relaxations were similar in control
and mecamylamine-treated rings, while the relaxations were significantly
reduced in atropine-treated preparations. In rings of 36 weeks old SHRs,
the remaining acetylcholine-induced relaxations in the presence of atropine
approximated 50% of those observed in untreated control preparations, while
in both 36 weeks and 64 weeks old WKY aortae the remaining response in
atropine- treated preparations was minimal. The response to acetylcholine
was nearly abolished in rings which had been incubated with mecamylamine
plus atropine. Thus in the SHR and WKY aorta, mAChRs are mainly
responsible for endothelium- dependent relaxations to acetylcholine under
control conditions. However, when mAChRs are inhibited by atropine,
nAChRs mediate relaxation to the cholinergic transmitter in the SHR but
not the WKY aorta.
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CALCITRIOL PROTECTS RENOVASCULAR FUNCTION OF
OVARIECTOMIZED RATS THROUGH THE DOWNR E G U L AT I O N O F C Y C L O OX Y G E NA S E - 2 A N D T P
RECEPTOR
J Dong,1 SL Wong,1 CW Lau,1 WT Wong,1 ZY Chen,2 X Yao,1 Y Huang1
1
Institute of Vascular Medicine and School of Biomedical Sciences;
2
Department of Biochemistry, The Chinese University of Hong Kong, Hong
Kong

showed that calcitriol reduced the elevated expression of COX-2 and TP
receptor in renal arteries from ovariectomized rats. The present results suggest
that the impaired endothelium-dependent relaxations in renal arteries of
ovariectomized rats are possibly attributed by the release of COX-2-derived
prostaglandin(s) that activate the TP receptor and that calcitriol normalizes
the renovascular function at least in part through COX-2 and TP receptor
down-regulation.

Exaggerated release of cyclooxygenase (COX)-derived contracting factors
can result in an impaired vasodilatation via TP receptor activation. While
Vitamin D may be beneficial to the cardiovascular function in addition to
its classical action on calcium homeostasis, its effect on renal vasculature
during estrogen deficiency is yet to be explored. The present study aims at
investigating changes in the renovascular reactivity in ovariectomized rats
and whether calcitriol, an active form of vitamin D, could reverse the altered
vascular function. Changes in isometric tension of the intrarenal arteries
from the sham and ovariectomized rats were recorded in microvessel
myograph. Expression levels of relevant proteins were analyzed by Western
blotting. Acetylcholine (ACh)-induced endothelium-dependent relaxations
were impaired in renal arteries from ovariectomized rats while their
endothelium-independent relaxations to sodium nitroprusside remained
unchanged as compared with the sham control. The non-selective COX
inhibitor, indomethacin (3 µM), improved the ACh-induced relaxations, and
so did the selective COX-2 inhibitor celecoxib (3 µM) but not the COX-1
inhibitor sc-560 (10 nM). Antagonist of thromboxane-prostanoid (TP)
receptor S18886 (0.3 µM) improved the relaxations. Western blot analysis

P14.
DOSE-RESPONSE RELATIONSHIP BETWEEN SMOKING,
S M O K I N G C E S S AT I O N S TAT U S A N D C A R OT I D
ATHEROSCLEROSIS: THE GUANGZHOU BIOBANK
COHORT STUDY-CVD
CQ Jiang, 1 L Xu, 1,2 TH Lam, 2 JM Lin, 1 WS Zhang, 1 B Liu, 1 YL Jin, 1
KK Cheng,3 GN Thomas3
1
Guangzhou No.12 Hospital, China; 2Department of Community Medicine,
School of Public Health, The University of Hong Kong, Hong Kong; 3Public
Health and Epidemiology, University of Birmingham, UK
Objective: To examine the dose-response relationship between smoking and
quitting smoking status with carotid atherosclerosis in 959 relatively healthy
Chinese men.
Methods: 959 men aged 50-85 years were randomly selected from phase III
(2006-2007) of the Guangzhou Biobank Cohort Study into this crosssectional study. Common carotid artery intima-media thickness (CCA-IMT)
was measured by B-mode ultrasonography, and carotid arterial plaques were
identified. Major cardiovascular risk factors, including fasting triglyceride,
LDL- and HDL-cholesterol, glucose, and systolic and diastolic blood pressure
were assessed.
Results: 1) Composition of the cases: 39.1% were non-smokers, 25.7% were
former smokers and 35.2% were current smokers. The mean (95% confidence
interval) carotid IMT was 0.78 (0.77-0.79) mm. 18.4% of the subjects had a
carotid IMT ≥1.0 mm, while 34.1% had carotid plaque. 2) After adjusting
for age, sex, physical activity, body mass index, fasting glucose, triglyceride,
HDL-cholesterol, systolic and diastolic blood pressure, compared to never
smokers, current smokers had significantly increased risk for thicker IMT
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and carotid plaque [odds ratio(OR)=1.82, 95%CI: 1.30-2.55 and OR=1.95,
95%CI:1.38-2.75, respectively, all P<0.001]. The risk for thicker IMT and
carotid plaque increased with the increasing amount (cigarettes/day) and
duration of smoking (years) as well with cigarette pack-years (P for trend
all ≤0.01). 3) Compared to current smokers, after adjustment for cigarette
pack-years and other potential confounders, the adjusted ORs (95% CI) for
the duration following quitting for 1-9, 10-19 and 20+ years were 0.77
(0.47 to 1.26), 0.45 (0.26 to 0.79) and 0.37 (0.17 to 0.77) for the presence of
CCA atherosclerosis, and 0.69 (0.43 to 1.12), 0.47 (0.27 to 0.82) and 0.45
(0.23 to 0.96) for the presence of carotid plaques, respectively.
Conclusion: An elevated risk with a clear dose-response relationship was
found between cigarette smoking and carotid atherosclerosis. Smoking
cessation was beneficial in attenuating the risk of carotid atherosclerosis
associated with a dose-response relationship with quitting time.
Acknowledgement: This project was supported by grants from the National
Natural Science Foundation of China (No. 30518001/CO301070202) and
the Hong Kong Research Grants Council (No. N-HKU720/05)
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THE POTENCY OF HUMAN INDUCED PLURIPOTENT STEM
CELLS (HIPS) DERIVED ENDOTHELIAL PROGENITOR
CELLS (EPC) IN THERAPEUTIC ANGIOGENESIS
WH Lai,1 JCY Ho,1,2 YK Li,1 KW Au,1 CW Siu,1,2 HF Tse1,2
Cardiology Division, Department of Medicine; 2Research Centre of Heart,
Brain, Hormone & Healthy Aging, Faculty of Medicine, The University of
Hong Kong, Hong Kong

1

Introduction: Experimental and clinical studies have shown that endothelial
progenitor cells (EPCs) can enhance angiogenesis in ischemic hindlimb
muscles and myocardium. However, the use of autologous EPCs
transplantation isolated from patients' blood are limited by their number
and proliferative potential. Human induced pluripotent stem cell (hiPS) is a
potential alternative cell source for EPC generation due to their autology,
high power of proliferation and pluripotency.
Methods: We characterize the phenotype and function of hiPS-derived EPCs
and compare them with human endothelial cell line (HUVEC) and human
embryonic stem cell derived EPC (H1-EPC). Donor specific Induced
pluripotent stem cells were generated from their skin fibroblast in feeder
free, serum free culture system and subsequently differentiated into EPCs.
Results: Two EPCs were generated (SIU1-EPC and IMR90-EPC) and
have similar morphology as H1 HES derived EPC. Positive vWF, ∝SMA,
Di-acetyl-LDL-DiI and Lectin staining was observed in both iPS-EPC and
H1-EPC. Tube formation assay revealed similar potential in forming capillary
with IMR90-EPC and SIU1-EPC as H1-EPC and HUVEC (13450±882,

15108±984.6 vs 14867.12±934.54 and 15349.59±1034.67 AU/well). Animal
model showed that the iPS derived EPSs can have comparable potential that
resume part of regional blood flow 28 days after left femoral artery occlusion
(IMR90-EPC and SIU1-EPC 35.5±6.2%, 37.9±5.5% vs H1-EPC and HUVEC
38.5±4.5%, 32.8±2.8%).
Conclusions: Our results demonstrate that hiPS-derived EPCs resemble
normal human endothelial cells with similar phenotypes and angiogenic
function but unlimited proliferation capacity. These findings suggest that
hiPS-derived EPC can be used as patient specific cell source in therapeutic
angiogenesis.

P16.
TNNI3K, A NEW MAP KINASE GENE, COULD BE A
MOLECULAR TARGET FOR THE TREATMENT AND
DIAGNOSTIC AGENTS ON CARDIAC DISEASES
ZF Lai
Department of Pharmacology and Molecular Therapeutics, Graduate School
of Medical Sciences, Kumamoto University, Japan
Objectives: TNNI3K is a novel cardiac-specific and troponin I (cTnI)interacting MAP kinase. Recently, we investigated the effects of TNNI3K
on P19CL6-derived cardiomyogenesis in vitro, and results indicated that
TNNI3K specifically interacted with cTnI by inhibiting cTnI phosphorylation
and played important roles in cardiac myogenesis. The aim of this study is
to evaluate whether TNNI3K overexpression can reduce myocardial ischemic
injury in mouse cardiac infarction model and whether plasma TNNI3K levels
can predict the occurrence of acute cardiac infarction (AMI) in patients or
not.
Methods and Results: A myocardial infarction (MI) model of mice was
made by ligation of left anterior descending branch of the coronary artery,
and the differentiated P19CL6 cells (induced 4 days in 1% DMSO) with
overexpressing TNNI3K was injected at four points, with 20 microliter per
point, in the border zone surrounding the infarcted area. TNNI3Koverexpression attenuated ventricular remodeling, improved impaired UCG
ejection fraction, left ventricular end-diastolic and end-systolic dimensions,
decreased the infarct size when compared with the medium-only or the
vector-only groups (P<0.05). To measure the circulating TNNI3K level in
AMI patients, a polyclonal anti-human TNNI3K antibody was raised in rabbit
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by injecting recombinant TNNI3K and purified as IgG by using protein Aconjugated sepharose column. Standard curve gained by enzyme-linked
immunosorbent assay (ELISA) was linear through the range from 0.011 to
11.00 ng/ml of TNNI3K protein. Plasma TNNI3K concentrations of healthy
volunteers, acute renal failure, chronic heart failure and acute myocardial
infarct patients measured by ELISA were 221.38±12.8 (n=21), 218.26±6.8
(n=6), 320.7±8.9 (n=18) and 2025.0±200.7 (n=18) ng/ml, respectively.
Results indicated that circulating TNNI3K level in AMI patients was
significantly higher than that in any other group (p<0.001). Specificity and
sensitivity to differentiate AMI from the other two was evaluated using
receiver operating characteristic curve analysis (MedCalc software) and
82.4% of specificity and 86.7% of sensitivity was gained by setting a cutoff value at 366 ng/ml.
Conclusions: Over-expressing the TNNI3K level would be a useful
therapeutic approach for ischemic cardiac diseases, and measurement of
plasma TNNI3K level may be a novel useful diagnostic tool for acute
myocardial infarction. Using TNNI3K as a molecular target may be a new
potential approach for developing remedies or diagnosis agents for ischemic
cardiac diseases.
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RUTAECARPINE RELAXES RAT MESENTERIC RESISTANCE
ARTERIES VIA THE RELEASE OF ENDOTHELIUM-DERIVED
NITRIC OXIDE AND NEUROGENIC CALCITONIN GENERELATED PEPTIDE
CW Lau,1 FP Leung,1 SL Wong,1 WT Wong,1 X Yao,1 Y Li,2 Y Huang1
1
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong, Hong Kong; 2 Department of
Pharmacology, School of Pharmaceutical Science, Central South University,
Hunan, China
Rutaecarpine, a bioactive alkaloid extracted from the dried fruit Evodia
rutaecarpa, is widely used to treat hypertension. However, its effect on
peripheral resistance arteries remains elusive. The present study characterizes
the vascular action of rutaecarpine in resistance arteries. Alterations in
isometric tension of the third-order Sprague-Dawley rat mesenteric resistance
arteries were studied in myograph. Field stimulation was applied to trigger
neurogenic relaxations. Real-time changes in intracellular calcium
concentration ([Ca 2+ ] i ) in native mesenteric endothelial cells and NO
production ([NO]i) in primary cultured mesenteric endothelial cells were
determined by confocal microscopy. Rutaecarpine caused potent relaxations
which were partially inhibited by N G -nitro-L-arginine methyl ester
(NOS inhibitor), ODQ (guanylate cyclase inhibitor) or in rings without
endothelium. Rutaecarpine-induced relaxations were attenuated by CGRP
receptor antagonist, CGRP (8-37) or depletion of CGRP from sensory nerves
by capsaicin. Field stimulation-induced relaxations were eliminated by

CGRP (8-37) and capsaicin. Rutaecarpine only partially relaxed mesenteric
arteries of eNOS knockout mice to an extent similar to the L-NAME-treated
arteries from the wild type mice, and the relaxations in eNOS knockout
mice were abolished by CGRP (8-37). Rutaecarpine stimulated rises in both
endothelial cell [Ca 2+] i and [NO] i. The present results demonstrate that
rutaecarpine exerts potent vasodilatory effects in resistance arteries by (1)
increasing eNOS activity and calcium-dependent NO formation in
endothelial cells, and (2) stimulating the neurogenic release of capsaicinsensitive CGRP which causes NO-independent relaxations. The concomitant
neurovascular effects in the resistance arteries are likely to account for the
reported blood pressure-lowering action of rutaecarpine.

P18.
CALCIUM HANDLING IN HUMAN INDUCED
PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
YK Lee,1# KM Ng,1# WH Lai,1 YC Chan,1 Q Lian,1,2 CP Lau,1 HF Tse,1,2 CW
Siu1,2
1
Cardiology Division, Department of Medicine, Queen Mary Hospital, The
University of Hong Kong; 2Research Center of Heart, Brain, Hormone and
Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong
Kong, Hong Kong
#contribute equally to this work
Although human induced pluripotent stem cells (hiPSCs) has brought
optimism and excitement to the field of cardiac regenerative medicine due
to its unquestioned potential to differentiate into cardiomyocytes, many
questions remain to be answered before clinical application can be
contemplated. The crucial first step is the characterization of the functional
properties of hiPSC-derived cardiomyocytes. However, the calcium handing
properties, the key process for excitation-contraction coupling, has not been
studied. In fact, the functional immaturity in calcium homeostasis may at
best result in poor graft-host integration, and at worst lead to potential lethal
arrhythmias, thus raising important safety issues for regenerative purposes.
This Here, we studied the calcium homeostasis of hiPSC-derived
cardiomyocytes in comparison with H7 hESC-derived cardiomyocytes with
fluorescence confocal microscopy. Cardiac differentiation of hiPSCs and
hESCs were induced with standard mesoderm induction protocol. Beating
outgrowth suggestive cardiomyocytes were first appeared on day 15.
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Compared with differentiated hESCs, differentiated hiPSCs appeared to have
a lower expression level of a panel of cardiac specific genes including
Nkx2.5, α-MHC and β-MHC. In addition, hiPSC-derived cardiomyocyes
exhibited an more immature calcium handling property in comparison with
hESC-derived cardiomyocytes with a significantly smaller amplitude and
slower maximal upstoke velocity (Vmax upstroke) in the spontaneous
calcium transients as well as caffeine induced calcium transient suggestive
poorly developed sarcoplasmic reticulum function. Consistently, the
expression level of the a few key calcium-handling proteins including
sodium-calcium exchanger (NCX-1) and sacroplasmic recticulum Ca 2+ATPase (SERCA) as well as the sarcoplasmic recticulum (SR) junctional
candidate, triadin (Trd), were significantly lower in hiPSC in comparison
with hESCs.
Conclusions: Taken collectively, hiPSCs exhibited immature calcium
handling properties, which may hamper its potential for future clinical
application.
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HEMIN RESTORES THE IMPAIRED ENDOTHELIUMDEPENDENT VASODILATATION IN DIABETIC db/db MICE
THROUGH PI3K/Akt PATHWAY
J Liu, WT Wong, XY Tian, LM Liu, SL Wong, CW Lau, J Yu, X Yao,
Y Huang
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong, Hong Kong
Heme oxygenase (HO) catalyzes heme into carbon monoxide, free iron and
biliverdin. A large amount of data demonstrates that HO-1, an inducible
isoform of HO, can exert vaso-protective effects. However, such vascular
benefit in diabetic vasculopathy remains largely unknown. The present study
investigates the impact of HO-1 induction on endothelial dysfunction in
type 2 diabetic db/db mice. Diabetic db/db and non-diabetic db/m+ mice
were treated with hemin (a potent inducer of HO-1) for two weeks or vehicle.
The aortae were isolated and suspended in myograph for force measurement
and levels of marker proteins were determined by the Western blotting
method. Two-week hemin administration restored the impaired endotheliumdependent relaxation to acetylcholine in db/db mice, which could be reversed
by co-treatment with HO-1 inhibitor SnMP. The effect of hemin could also
be blocked by 24 h-culture with PI3K inhibitor Wortmannin. In addition, 24
h-culture with bilirubin improved the impaired endothelium-dependent
relaxation to acetylcholine in db/db mice. Finally, hemin treatment enhanced
the eNOS and Akt phosphorylation level in the vascular wall. The present
study provides clear evidence for the protective role of HO-1 induction
against endothelial dysfunction in a mouse model of diabetes. (Supported
by Hong Kong GRF and CUHK Focused Investment Scheme)

P20.
MELATONIN ATTENUATES INTERMITTENT HYPOXIA
I N D U C E D O X I D AT I V E S T R E S S A N D T I S S U E
INFLAMMATION IN RAT ADRENAL MEDULLA
Y Liu, ML Fung
Department of Physiology, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong
Patients with sleep-disordered breathing suffer from intermittent hypoxia
(IH). Previous studies have shown that chronic exposure to IH associated
with recurrent apnoea induces oxidative stress and pathophysiological
changes in the cardiovascular system. The adrenal medulla is responsive to
acute hypoxia and plays an important role in the cardiovascular response to
hypoxia. Yet, the chronic effect of IH on the adrenal medulla is currently
undefined. We hypothesized that the free radical scavenger melatonin can
attenuate the IH-induced oxidative stress and local injury and inflammation
in the adrenal medulla. Adult Sprague-Dawley rats were exposed to air or
IH mimicking a severe condition of sleep apnoea for 14 days. An
intraperitoneal injection of melatonin (10 mg/kg) or vehicle was given daily
prior to the IH treatment. The adrenal medulla was harvested for the
measurement of markers for oxidative stress, malondialdhyde (MDA) and
nitrotyrosine, and for the histological analysis of macrophages infiltration
and TUNEL staining for apoptosis. Also, the protein expression of iNOS
was examined by western blot. Our results showed that the MDA level was
significantly increased in the IH group, when compared with the Nx control
and melatonin-treated IH group. Image analysis also showed significantly
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more percentage area of the adrenal medulla with positive immunostaining
of NTR than that of the Nx group and the melatonin-treated IH group. In
addition, macrophage marker ED1-immunoreactivity was remarkable and
the protein expression of iNOS was also significantly increased in the IH
group, suggesting a local inflammation induced by IH in the adrenal medulla.
Moreover, there was an increase in the number of apoptotic cells in the
adrenal medulla of IH rats, and the increase was ameliorated in the IH group
treated with melatonin. In conclusion, our results support the hypothesis
that IH-induced oxidative stress is involved in the local inflammation and
apoptosis in the adrenal medulla. The antioxidant melatonin can effectively
attenuate the IH-induced tissue injury and inflammation in the rat adrenal
medulla.
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N-ACETYL-L-CYSTEINE REDUCES HIGH GLUCOSEINDUCED MITOCHONDRIAL ROS GENERATION AND
CORTICAL F-ACTIN CYTOSKELETON LEVELS IN
PANCREATIC ISLETS β-CELLS OF OBESE/DIABETIC MICE
CCW Poon,1 ALS Au, 1 Q Zhang,1 SK Kong,2 HP Ho, 3 GPH Leung,4 YW
Kwan1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese
University of Hong Kong; 2School of Life Sciences, Faculty of Science,
The Chinese University of Hong Kong; 3 Department of Electronic
Engineering, Faculty of Engineering, The Chinese University of Hong Kong;
4
Department of Pharmacology and Pharmacy, Faculty of Medicine, The
University of Hong Kong, Hong Kong
Background: Failure of insulin secretion associated with β-cell dysfunction
caused by glucotoxicity is a key factor in the development and progression
of type 2 diabetes mellitus (T2DM). The beneficial effects of anti-oxidants
consumption on treating T2DM remains to be determined. Therefore, in
this study, we tested the hypothesis that L-NAC (an antioxidant) incubation,
in vitro, restores the insulin secretory dysfunction via the modulation of
mitochondrial ROS generation and cortical F-actin cytoskeleton levels of
pancreatic islets b-cells of obsess/diabetic (db+/db+) mice (an animal model
for human T2DM research).
Experimental approaches: The pancreatic islets of age-matched (female;
~6 month-old) lean/control (db+/m+) and obese/diabetic (db+/db+) of
C57BL/KsJ mice were isolated using collagenase; single pancreatic β-cells
of both strains of mice were further isolated by trypsin. Effects of L-NAC
(20 mM; 24-hr incubation) on mitochondrial ROS generation, insulin release/

content and cortical F-actin cytoskeleton levels of pancreatic islets/single
β-cells (bathed in normal (5 mM) and high (15 mM) glucose culture medium)
of both strains of mice were evaluated and compared.
Results: A higher level (the basal and high glucose-induced) of mitochondrial
ROS was detected in single pancreatic β-cells of db+/db+ mice, compared
to db+/m+ mice. L-NAC (20 mM, 24 hr incubation) significantly attenuated
high glucose-induced mitochondrial ROS generation in single pancreatic
β-cells of (db+/db+) mice. A consistently lower level of insulin release (in
response to 15 mM glucose) and insulin content was measured in isolated
pancreatic islets of db+/db+ mice, and L-NAC incubation significantly
enhanced glucose-induced insulin release and the insulin content of
pancreatic islets of both species. A consistently higher level of cortical Factin cytoskeleton was observed in single pancreatic β-cells of db+/db+
mice (irrespective of glucose levels in the culture medium) which was
markedly attenuated by L-NAC. No apparent change of cortical F-actin
cytoskeleton level, in response to L-NAC, was observed in single pancreatic
β-cells of db+/m+ mice.
Conclusions: Our results demonstrate that L-NAC incubation is effective in
suppressing high glucose-induced oxidative stress and attenuating cortical
F-actin cytoskeleton levels which are probably responsible for the observed
enhancement of insulin release/content of pancreatic β-cells of obese/diabetic
(db+/db+) mice.
Acknowledgements: This project is financially supported (to YWK) by RGC
Research Grant of Hong Kong SAR (Reference no: 2140565). Provision of
post-graduate (MPhil) studentship to Ms. CCW Poon by School of
Biomedical Sciences (The Chinese University of Hong Kong) is
acknowledged.

P22.
ERGOTHIONEINE PROTECTS ENDOTHELIAL CELLS
FROM OXIDATIVE STRESS
ASM Sit,1 EYW Ho,1 RWS Li,1 RYK Man,1 YW Kwan,2 M Hausman,3 PM
Vanhoutte,1 GPH Leung1
1
Department of Pharmacology and Pharmacy, The University of Hong Kong;
2
School of Biomedical Sciences, The Chinese University of Hong Kong;
3
Total Nutraceutical Solutions, Hong Kong
Ergothioneine is a chemical abundant in mushroom. It possesses strong
antioxidant properties by removing toxic radical species or chelating metal
ions. However, these antioxidant properties are mainly studied in simple
cell-free systems. In addition, unlike other water soluble antioxidants,
ergothioneine is cell membrane impermeable and requires the specific carrier
OCTN1 to be internalized. This OCTN1 is not ubiquitously expressed in all
tissues. Therefore, their relevance to the actual function of ergothioneine in
the body has been questioned.

cells were incubated in medium containing 25 mM (which mimics
hyperglycemic condition in diabetes) instead of 5 mM glucose. Interestingly,
ergothioneine (in a concentration as low as 10 nM) was able to reduce the
detrimental effect of 25 mM glucose. In addition, 1 mM ergothioneine could
reduce the cytotoxic effect of 600 nM hydrogen peroxide on HBMECs.
In conclusion, our findings suggest that ergothioneine can be taken up by
endothelial cells, probably through OCTN1. Besides, ergothioneine is a
potential agent that can protect endothelial cells against oxidative stress.

In this study, we aimed to investigate whether or not ergothioneine can enter
endothelial cells and protect endothelial cells against cellular damage induced
by oxidative stress. Human brain microvascular endothelial cells (HBMECs)
were used in this study. The results of RT-PCR demonstrate the expression
of OCTN1 in HBMECs. Consistently, [3H]ergothioneine could be taken up
by HBMECs through a sodium-dependent and transporter-dependent system.
MTT assay shows that the viability of HBMECs was decreased when the
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P24.

BLACK TEA POLYPHENOLS IMPROVE ENDOTHELIAL
FUNCTION IMPAIRED BY HOMOCYSTEINE IN RAT
AORTAS

ROLE OF JUMI EXTRACTION IN ACUTE RENAL FAILURE
RATS

YY Tam,1 WT Wong,1 XY Tian,1 WS Cheang,1 CW Lau,1 AM Xu,2 Y Huang1
1
Institute of Vascular Medicine and School of Biomedical Sciences, The
Chinese University of Hong Kong, Hong Kong; 2Department of Medicine
and Department of Pharmacology, China
Objectives: Homocysteine is a well-known risk factor of cardiovascular
disease. Hyperhomocysteinemia is found in patients with atherosclerosis
and myocardial infarction. Homocysteine also impairs endotheliumdependent vasodilatation. Tea consumption is known to reverse endothelial
dysfunction in patients with cardiovascular disease. This study aims at
investigating whether homocysteine-induced endothelial dysfunction
involves endoplasmic reticulum (ER) stress, and whether black tea
polyphenols can improve endothelial function impaired by homocysteine.
Methods: Vasoreactivities of rat aortas were assessed in wire myograph.
Protein expressions were examined by Western blotting.
Results: Homocysteine impairs endothelium-dependent relaxations (EDRs)
of rat aortas in a concentration-dependent manner. ER stress alleviator sodium
4-phenylbutyrate (PBA) increases EDRs impaired by Homocysteine. A
mixture of theaflavins (TE) and theaflavin-3,3'-digallate (TF3) also improves
EDR impaired by Homocysteine. In addition, Western blotting showed
homocysteine increased eIF2α phosphorylation in rat aortic endothelial cells,
which was inhibited by PBA, and theaflavins.
Conclusions: The present study provides evidences for the possible
involvement of ER stress in homocysteine-induced endothelial dysfunction,
it also suggests that theaflavins improve endothelial function impaired by
homocysteine.

M Wang, ML Xia , XM Zhou, XY Xie
Department of Physiology, Jiaxing University, School of Medicine, China
Objective: The purpose of this study is to investigate the effect of jumi
extraction on acute renal failure (ARF) rats: role of thyrosine hydroxylase
(TH) in hypothalamus paraventricular (PVN) and kidney.
Methods: Male SD rats were randomly divided into four groups: control
group, ARF group, Jumi extraction group and ARF+ Jumi extraction group.
Glycerol-induced acute renal failure in rats was employed. Malondialdehyde
(MDA) and reduced glutathione hormone (GSH) in renal cortex homogenate
were measured by commercial kits. Electron microscope were used to
examine the pathological changes. Meanwhile the expressions of TH in
kidney were evaluated by immunohistochemistry.
Results: ARF rats administrated orally with 2 mL of normal saline for 48 h
showed a significant increase in MDA (P<0.05), but GSH markedly decreased
(P<0.05), when compared with that in control group. After treatment of
ARF rats with jumi extraction for 48 h, MDA were significantly decreased
(P<0.05), but GSH markedly increased (P<0.05), and the severity of tubular
necrosis was alleviated when compared with that in ARF group.
Immunohistochemistry showed obvious increase of thyrosine hydroxylaseimmunoreactivity (TH-IR) in PVN and kidney in ARF group (P<0.05), but
TH-IR was further enhanced in ARF+ Jumi extraction group (P<0.05).
Conclusion: The results indicated that jumi extraction could have a strong
renal protective effect against ARF. TH in PVN and kidney may contribute
to renal protective effect of jumi extraction against ARF.

P25.
RATE-DEPENDENT BLOCK OF HKV1.5 CHANNELS AND
THE MOLECULAR DETERMINANT BY THE NATURAL
FLAVONE ACACETIN
HJ Wu, W Wu, GR Li
Department of Medicine, The University of Hong Kong, Hong Kong

acacetin blocks both closed and open channels of hKv1.5 by binding to the
S6 domain of hKv1.5 channels. The use- and rate-dependent blocking
property of hKv1.5 by acacetin indicates that this natural compound could
exert a strong suppressive effect on atrial fibrillation in man.

We have recently demonstrated that the natural flavone acacetin is an atrialselective compound that inhibits ultra-rapid delayed rectifier potassium
current (IKur) and transient outward potassium current (Ito) in human atrial
myocytes, and also acetylcholine-activated potassium current (I K.ACh). It
increased atrial effective refractory period and effectively prevented atrial
fibrillation (AF) in anesthetized dogs without prolonging QT interval of
ECG. The present study was designed to determine whether the IKur block of
acacetin is rate- and/or use-dependent, and the molecular determinant of
the channel block in HEK 293 cells expressing hKv1.5 channels (coding
IKur in human atrial myocytes). It was found acacetin exhibited open channel
block of hKv1.5 channels at 3 µM, and both closed and open channel block
at 10 µM. Block of hKv1.5 channels by acacetin was use- and frequencydependent, and the IC50 of acacetin for inhibiting hKv1.5 was reduced by
increasing the depolarization rate from 3.5 µM at 0.2 Hz to 3.1, 2.9, 2.1,
and 1.7 µM respectively at 0.5, 1, 3, and 4 Hz. The mutagenesis study showed
that the hKv1.5 mutant V505A and I508A in the S6-segment remarkably
reduced the channel block by acacetin (IC 50, 28.7 µM for V505A and
19.4 µM for I508A). These results demonstrate the novel information that
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CONTRAST OF MEAN ARTERIAL BLOOD PRESSURE,
HEART RATE AND AORTIC TENSION INDUCED BY CLP &
LPS SEPTIC SHOCK IN RATS
ML Xia, M Wang, YY Huang
Department of Physiology, College of Medicine, Jiaxing University, China
Objective: To observe the differences of mean arterial blood pressure
(MABP), heart rate (HR) and thoracic aorta tension induced by two septic
shock models in rats and explore the possible mechanism.
Methods: we used cecal ligation and puncture (CLP) 20 hours and
lipopolysaccharide (LPS) 6 hours to establish septic shock in rats. The carotid
artery was cannulated and connected to a pressure transducer to determine
mean arterial blood pressure (MABP). Ventricular dynamic parameters were
determined following intraventricular cannulation via the carotid artery,
including heart rate (HR), left ventricular developed pressure (LVDP),
maximal rise/fall velocity of ventricular pressure (±dP/dtmax). Isolated
thoracic rings were mounted on an organ bath and the tension of the vessel
was recorded.
Results: (1) The mortality was 65.2% (30/46) in CLP shock rats, but no rats
dead in LPS shock rats (0/24); (2) The two models showed significant
decrease in MABP and HR, and CLP model's decrease more(P<0.01)
(CLP decrease 55.7% and 71.5%, LPS decrease 41.5% and 58.3%);
(3) Constriction by high K+ (60 mmol/L) or 10-6 mol/L phenylephrine (PE)
in endothelium-intact aortic rings were all decrease, and LPS model's

decrease more (P<0.01) (CLP decrease 22.8% and 26.4%, LPS decrease
70.1% and 72.9%). And constriction by high K + or PE in endotheliumdenuded aortic rings had the similar decrease.
Conclusion: The ventricular-dynamic parameters and vasoconstriction
responsiveness of aorta were all decrease in two septic shock models in rats.
CLP model's decrease more in the ventricular-dynamic parameters, though
LPS model's decrease more in vasoconstriction responsiveness of aorta.

P27.
T E L M I S A RTA N P R O M OT E S R E L A X AT I O N S B Y
INCREASING PPAR γ -DEPENDENT NITRIC OXIDE
PRODUCTION IN MOUSE MESENTERIC ARTERIES
CY Yuen,1 SL Wong,1 CW Lau,1 B Tomlinson,2 X Yao,1 Y Huang1
1
Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences,
School of Biomedical Sciences and 2 Department of Medicine and
Therapeutics, The Chinese University of Hong Kong, Hong Kong

increased the basal and ACh-stimulated NO production, and both were
prevented by GW9662. Taken together, the present results indicate that
telmisartan enhances endothelium-dependent relaxations in resistance
arteries, which is mediated through PPARγ-dependent elevation of NO
production as a result of the increased eNOS expression and activity, possibly
independent of AT1R blockade. PPARγ agonistic activity of telmisartan may
offer additional vascular benefits in addition to the known AT1R antagonistic
effect.

Telmisartan robustly activates peroxisome proliferator-activated receptor-γ
(PPARγ) besides serving as an angiotensin II type 1 receptor (AT1R) blocker.
It has been suggested that the activation of PPARγ exerts beneficial effects
on the vascular function. However, the PPARγ agonistic effect of telmisartan
on resistance arteries is unclear. The present study aimed at investigating
whether telmisartan promotes relaxations in mouse mesenteric resistance
arteries by stimulating the expression and activity of endothelial nitric oxide
synthase (eNOS), which in turn augments nitric oxide (NO) production via
the PPARγ-dependent mechanism. Second-order mesenteric arteries from
male C57BL/6J were isolated and cultured overnight with telmisartan,
afterwhich changes of their isometric tension were measured in myographs.
Expression and activation of relevant proteins were analyzed by Western
blotting. Real time changes in intracellular NO level in human endothelial
cells was monitored by confocal microscopy. Telmisartan (10 µM) enhanced
acetylcholine (ACh)-induced endothelium-dependent relaxations, which
were inhibited by a PPARγ antagonist, GW9662 (300 nM). Telmisartan upregulated GW9662-sensitive eNOS expression and phosphorylation, which
were absent in PPARγ knockout (KO) mice. Additionally, telmisartan
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ROLE OF AMPK AND HMG COA REDUCTASE IN
SIMVASTATIN-MEDIATED INSULIN RELEASE FROM
P O R C I N E I S O L AT E D PA N C R E AT I C I S L E T S O F
LANGERHANS
Q Zhang, 1 MF Wong, 1 FY Kwok, 1 ALS Au, 1 CCW Poon, 1 GPH Leung, 2
SK Kong,3 HP Ho,4 CH Cho,1 YW Kwan1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese
University of Hong Kong; 2Department of Pharmacology and Pharmacy,
Faculty of Medicine, The University of Hong Kong, 3School of Life Sciences,
Faculty of Science, The Chinese University of Hong Kong and 4Department
of Electronic Engineering, Faculty of Engineering, The Chinese University
of Hong Kong, Hong Kong
Background: Diabetes mellitus (DM) is a medical disorder characterized
by a persistent hyperglycemia especially after meals. In DM patients, there
is a deficiency/absence of insulin release. The ability of HMG CoA reductase
inhibitors (statins) to decrease the incidence of diabetes in patients with
dyslipidemia has also been documented. However, the underlying
mechanisms involved for the beneficial effects of the uses of statins in treating
DM have not been elucidated in details.
Methods: Fresh porcine pancreatic islets of Langerhans were isolated from
porcine pancreases. Then, isolated islets were incubated with or without
simvastatin (a commonly used HMG CoA reductase inhibitor) in medium
with different glucose levels (5 and 25 mM). The protein expression of HMG
CoA reductase, p-HMG CoA reductase-Ser871, AMPK and p-AMPK-Thr172
was determined. Insulin release was measured using ELISA kits.

Results: The biochemical existence of HMG CoA reductase was
demonstrated in pancreatic islets of Langerhans, and the expression of HMG
CoA reductase was glucose (5 mM and 25 mM)-dependent (~ 40% increase).
Simvastatin (10 µM, 24 hr incubation) caused a decrease in HMG CoA
reductase expression irrespective of glucose levels. There was no apparent
change of p-HMG CoA reductase expression caused by both glucose levels
except with simvastatin (10 µM, with 25 mM glucose). An increase of pAMPK-Thr172, but not AMPK, expression was detected under high glucose
conditions which was reduced by simvastatin. Simvastatin elicited a
concentration (0.01, 0.1 and 10 µM)-dependent insulin release (3.6-fold
and 8.5-fold increase with 0.1 and 10 mM simvastatin, respectively) from
isolated islets bathed in 5 mM glucose medium. No apparent change caused
by simvastatin was observed under high glucose (25 mM) conditions.
Conclusions: Our results demonstrate the biochemical existence of HMG
CoA reductase in porcine's pancreatic islets. Simvastatin elicited a
concentration-dependent insulin release under normal glucose conditions
which is related to an inhibition of p-AMPK expression.
Acknowledgements: Provision of fund to Ms. Lori FY Kwok (summer of
2010) by the School of Biomedical Sciences (Faculty of Medicine, CUHK)
is acknowledged. This project was financially supported by GRF Grant (to
YWK) (Reference number: 2140565).

P29.
MONOAMINE OXIDASE-A-MEDIATED GENERATION OF
REACTIVE OXYGEN SPECIE BY 5-HYDROXYTRYPTAMINE
IN HUVECS
Q Zhang, 1 ALS Au, 1 CCW Poon, 1 GPH Leung, 2 SK Kong, 3 HP Ho, 4
YW Kwan1
1
School of Biomedical Sciences, Faculty of Medicine, The Chinese
University of Hong Kong; 2Department of Pharmacology and Pharmacy,
Faculty of Medicine, The University of Hong Kong, 3School of Life Sciences,
Faculty of Science, The Chinese University of Hong Kong and 4Department
of Electronic Engineering, Faculty of Engineering, The Chinese University
of Hong Kong, Hong Kong
Background: 5-Hydroxytryptamine (5-HT), a potent vasoactive
neurotransmitter, after released is terminated at the nerve terminals mainly
via enzymatic metabolism such as monoamine oxidases (MAOs), resulted
in the generation of different metabolites (e.g. 5-HIAA, 5-HTOL and H2O2).
In HUVECs, generation of H2O2 and the role(s) of MAOs in response to
5-HT challenge is unknown.
Methodology: Cultured human umbilical vein endothelial cells (HUVECs)
(passages: 4-6) were used. ROS generation elicited by 5-HT in the absence
or presence of L-NAME (an eNOS inhibitor) was evaluated using H2DCF
fluorescence dye by flow cytometry. Mitochondrial H 2O 2 levels were
estimated by MitoTracker Red (reduced form) (a selective fluorescence probe
for mitochondrial H 2 O 2 measurement) using confocal laser scanning
microscope. The participation of a particular isoform of MAOs (MAO-A
and MAO-B) was evaluated using selective MAO inhibitors (MAO-A:
clorgyline; MAO-B, selegiline).
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Results: In the presence of L-NAME (100 µM), 5-HT consistently elicited
a concentration (0.3, 0.6, 1, 3 and 10 µM)- and time (10-30 min)-dependent
increase in ROS generation. Antimycin A (10 µM, a positive control) caused
ROS generation in HUVECS as by 5-HT. 5-HT-induced ROS generation
was sensitive to clorgyline (10 µM) and citalopram (10 µM, a selective
5-HT transporter inhibitor) but not to selegiline (10 µM) or GR127935
(10 µM, a 5-HT1B/1D receptor antagonist). 5-CT (a 5-HT analogue), 5-HIAA
(10 µM), 5-HTOL (10 µM) and acetylcholine (10 µM) failed to cause ROS
generation.
Conclusions: Our result clearly demonstrates that 5-HT elicits mitochondrial
ROS production (a 5-HT1B/1D receptor-independent manner) probably via
MAO-A-mediated 5-HT metabolism in HUVECs.
Acknowledgements: Provision of a post-graduate (PhD) studentship to
Ms. Q Zhang by School of Biomedical Sciences (Faculty of Medicine, The
Chinese University of Hong Kong) is acknowledged.
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GENDER-SPECIFIC RELAXATION OF FLAVONOIDS IN RAT
MESENTERIC ARTERIES
Y Zhang, SWS Leung, RYK Man
Department of Pharmacology and Pharmacy, The University of Hong Kong,
Hong Kong
Flavonoids are considered as plant-derived estrogens. Estrogen shows
different vascular effects in male and female. This study examined whether
or not there is a gender difference in the vascular effects of flavonoids. The
effects of genistein, daidzein, quercetin and luteolin on nitric oxide (NO)and endothelium-derived hyperpolarizing factor (EDHF)-mediated
relaxations to acetylcholine were studied in mesenteric arteries of 8- and
28-week-old male and female Sprague-Dawley rats. EDHF-mediated
relaxation was greater in 8-week-old female than in age-matched male rat
mesenteric arteries. This gender difference was not observed in the presence
of genistein, quercetin and luteolin. NO-mediated relaxations were not
different between 8-week-old male and female rat mesenteric arteries.
Luteolin caused a greater enhancement in NO-mediated relaxations in male
than in female. In 28-week-old male and female rat mesenteric arteries,
daidzein, quercetin and luteolin impaired EDHF-mediated relaxation in male
mesenteric arteries. Gender difference was not observed in NO-mediated
relaxation in 28-week-old rat mesenteric arteries, with or without flavonoids.
The data suggests that genistein, quercetin and luteolin produce beneficial
vascular effects in young male rats. However, EDHF responses were impaired
by daidzein, quercetin and luteolin in older male rats. Therefore, the vascular
effects of flavonoids are affected by both gender and age.

P31.
GLP-1(9-36)AMIDE AND EXENDIN-4 PROTECT ISOLATED
CARDIOMYOCYTES FROM ADULT RATS AGAINST
ISCHEMIA-REPERFUSION INJURY THROUGH DIFFERENT
PATHWAYS
Z Li,1 LB Qian,1,2 ML Xia,3 HP Wang,1 M Treiman,2 Q Xia1
1
Department of Physiology, Zhejiang University School of Medicine,
Hangzhou 310058, China; 2Department of Biomedical Sciences, University
of Copenhagen, Copenhagen, Denmark; 3Department of Physiology, Medical
School, Jiaxing College, Jiaxing 314001, China
Background: Glucagon-like peptide-1 (GLP-1), usually recognized as a
gut hormone with potent plasma glucose-lowering action, is rapidly cleaved
by the widely expressed dipeptidyl peptidase-4 enzyme at the N terminus to
generate GLP-1 (9-36) amide. More recently, both GLP-1, its analogues
exendin-4 (Exe-4) and GLP-1(9-36) amide have been show ed
cardioprotective actions in a number of experimental models. However, the
mechanisms underlying the actions of GLP-1 and GLP-1 (9-36) amide remain
poorly understood.
Objective: To investigate the signaling pathways of GLP-1 (9-36) amide
and Exe-4 (both in the concentration of 1 nM) protecting the isolated
cardiomyocyte from adult rats against ischemia-reperfusion (IR) injury.
Methods: When administered, the agents were presented for 10 min before
25 min simulated ischemia (glucose oxidase-catalase oxygen-scavenging
system) and the whole reperfusion period.
Results: After 5 minutes reperfusion, both GLP-1 (9-36) amide and Exe-4
strongly reduced trypan blue-sensitive cells (from 53.57±7.68% in IR
group to 39.29±3.02% and 41.53±6.73%, P<0.01). This cell death-limiting
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effect of GLP-1(9-36) amide was abolished by endothelial nitric oxide
synthase (eNOS) inhibitor L-NAME, MEK1/2 inhibitor U0126 or protein
kinase A (PKA) inhibitor H89, but not by GLP-1 receptor antagonist exendin
(9-39), phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 or
wortmannin. In contrast, such effect of Exe-4 was abolished by exendin
(9-39), L-NAME, or LY294002 and wortmannin. All of the inhibitors alone
had no effect on IR cardiomyocytes.
Conclusion: The results indicate that separate actions for GLP-1 (9-36) amide
vs. GLP-1 analogues Exe-4 against ischemia-reperfusion death in
cardiomyocytes isolated from adult rats, and reveal that the cardioprotective
effect of GLP-1 (9-36) amide is independent on GLP-1 receptor, but through
MEK, eNOS and PKA signaling pathways, while Exe-4 exerts
cardioprotective effect through GLP-1 receptor, PI3K and eNOS signaling
pathways.
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P32.
ADVANCED GLYCATION END PRODUCT INDUCES
ENDOTHELIAL DYSFUNCTION IN MOUSE AORTAS
THROUGH MITOCHONDRIAL REACTIVE OXYGEN SPECIES
Y Lu, XY Tian, WT Wong, LM Liu, J Liu, CW Lau, X Yao, Y Huang
Institute of Vascular Medicine and School of Biomedical Sciences, Chinese
University of Hong Kong, Hong Kong
Objectives: Increased production of advanced glycation end-products (AGEs)
contributes to endothelial dysfunction in diabetes. The present study examines
whether AGE could exert a direct vascular action and the possible mechanisms
involved.
Methods: Aortas from db/m+ mouse were treated with AGE-BSA at 10 µg/ml
for 24 hours in the absence or presence of pharmacological inhibitors. Wire
myograph was used to assess changes in the vascular reactivity of arteries.
Production of mitochondria-derived reactive oxygen species (ROS) was
determined using MitoSOX fluorescence under confocal microscope. Western
blot was used to assay the p47 level in db/m+ mouse aortas after AGE treatment
with or without inhibitors.
Results: The present study shows that AGEs reduced acetylcholine-induced
endothelium-dependent relaxations (EDRs) in aortas from db/m+ mice and
AGE-induced impairment of EDRs was reversed by co-incubation with AGE
inhibitor aminoguanidine, NADPH oxidase inhibitor DPI and apocynin,
mitochondrial ROS scavenger mitoQ, and protein kinase C inhibitors
GF 109203X and chelerythrine. AGE treatment increased the mitochondrial
ROS production in native endothelium of intact mouse aortas and in primary
mouse aortic endothelial cells, which were inhibited by DPI, apocynin, mitoQ,
and ROS scavenger Tiron+DETCA. Western blot data show that a p47 upregulation by AGE was reversed by aminoguanidine, DPI, apocynin, mitoQ,
and also PKC inhibitors.
Conclusions: The present study suggests that AGEs impair endothelial function
through NADPH oxidase- and PKC-dependent increase of mitochondrial ROS,
which may contributes to diabetes-related vascular dysfunction. (supported
by Hong Kong GRF)

P33.
IN VITRO SYNERGISTIC BONE ANABOLIC EFFECTS OF
α DIHYDROXYVITAMIN D 3 AND CU409B1 IN RAT
1,25α
OSTEOBLASTS
LCM Lau,1 WYW Lee,2 AKF Chan,1 CCW Poon,1 PPY Lui,2 CKM Chan,2
SK Kong,3 GPH Leung,4 YW Kwan1
1
School of Biomedical Sciences; 2 Department of Orthopaedics and
Traumatology, Faculty of Medicine; 3School of Life Sciences, Faculty of
Science, The Chinese University of Hong Kong; 4 Department of
Pharmacology and Pharmacy, Faculty of Medicine, The University of Hong
Kong, Hong Kong
Background: Osteoporosis is a disease of bones with increased risk of bone
fracture because of reduced bone mineral and disrupted bone microarchitecture. The disease is mainly due to increased osteoclasts activity and/
or reduced osteoblasts activity. Vitamin D3 (Vit. D3) is one of the medications
for osteoporosis as it enhances Ca2+ absorption from diets. Previous findings
in our laboratory demonstrated that CU409B1 (patent pending on chemical
structure) improved rats osteoblasts differentiation. In this study, we tested
the hypothesis that a combination of CU409B1 and Vit. D3 (at the lowest
plasma concentration, 10 nM) provided synergistic bone anabolic effects.
Methods: Primary rat osteoblasts were isolated from Sprague Dawley (SD)
rats (female, 6 weeks old) (sacrificed using an over-dose of pentobarbital).
Iliac crests collected were immediately immersed in PBS (for 10 min)
supplemented with 10X antibiotics, and bone marrow was removed and the
crests were washed thoroughly twice with plain low glucose-DMEM (LGDMEM). Trabecular bones were harvested, cut into small pieces, and immersed
in LG-DMEM (10% fetal bovine serum with 1X antibiotics) for cultured in a
humidified incubator (37oC and 5% CO2). Cells reached over 90% confluence
were treated with either 1,25α dihydroxyvitamin D3 (10 nM, the active form
of Vit. D3), CU409B1 (10 nM) or a combination of Vit. D3 (10 nM) plus
CU409B1 (10 nM) for 7 days before subjecting to analysis of various
biomarkers. mRNA was isolated and subjected to quantitative real-time reverse
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transcription polymerase reaction (qRT-PCR) to determine the levels of
osteogenesis-related mRNAs, including alkaline phosphatase (ALP), bone
morphogenetic protein 2 (BMP2), osteopontin (OPN), osteocalcin (OCN),
pro-collagen type I, and Runt-related transcription factor 2 (RunX2). The extent
of osteogenesis was determined by measuring the activity of extracellular
ALP and Alizarin Red staining of Ca2+ deposits.
Results: At day 7, a combination of CU409B1 (10 nM) and 1,25α
dihydroxyvitamin D3 (10 nM) significantly enhanced the mRNA levels of
ALP, OCN, BMP2, and pro-collagen type I (P<0.05) whereas no apparent
change was observed in osteoblasts treated with either CU409B1 (10 nM) or
1,25α dihydroxyvitamin D3 (10 nM) alone. However, no significant change
of ALP activity and calcium deposition by all drug treatments was observed.
Conclusions: Our results demonstrate that a combination of CU409B1 and
1,25α dihydroxyvitamin D3 treatment (7 days) have osteogenesis effects.
Current study is underway to elucidate the cellular signaling pathways
involved.
Acknowledgements: Fund provided to Mr. Lawrence CM Lau (summer of
2010) by the School of Biomedical Sciences (Faculty of Medicine, CUHK) is
acknowledged.
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